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Abstract 
Ageing as a biological process is ubiquitous in life. In humans, ageing and its related 
conditions are revealed with improvements in health care conditions. Evidence for 
ageing is also apparent in most other organisms including unicellular species. Many 
of the pathways and mechanisms involved in ageing are evolutionarily conserved 
across the tree of life which provides an exceptional opportunity to study simpler 
organisms and extend the results to more complex forms of life. There is a rapidly 
growing body of data from organisms of varying levels of complexity, but there is a 
shortage of attempts in coherently making use of these data. A systems-level approach 
is necessary to bridge the gap between different biological levels, integrate the 
available information, and enable the synthesis of unifying hypotheses. Also, given 
the evolutionary nature of the question at hand (i.e. ageing), a successful hypothesis 
needs to be able to account for evolutionary considerations. In this thesis, I take a 
theoretical approach and try to explain a number of aspects of ageing from a systems-
level perspective in an evolutionary context. Among the topics that will be covered 
are the following: (i) intra-islet pancreatic beta-cell dynamics, (ii) antioxidant defence 
system in pancreatic beta-cells, (iii) metabolic evolution of the glucose homeostatic 
system, and (iv) asymmetric damage segregation in unicellular organisms. In (i), I 
investigate the dynamics of beta-cell number within pancreatic islets and link the 
results to pathophysiology of diabetes and its various stages. In (ii) and (iii), I provide 
a unifying hypothesis for the paradoxical and unequivocal observation that 
metabolically active beta-cells have a weak antioxidant defence system and 
interestingly, that they are particularly weak in females. In (iv), I show how 
asymmetric segregation of damage at the time of mitosis is a fundamental step toward 
ageing and then evaluate whether and by how much asymmetry is optimal in a given 
organism under certain environmental conditions. I use a variety of techniques 
including deterministic and stochastic modelling in this thesis. The shared essence of 
these projects is an attempt to put data of various sources together in a unifying, 
systems-level evolutionary framework in order to better understand some aspects of 
the ageing process and its consequences.       
 
 
 
 
3 
 
Acknowledgements 
I thank my supervisors Dr Daryl Shanley and Professor Tom Kirkwood. My research 
was supported by a UK Dorothy Hodgkin Postgraduate Award.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
 
 Table of contents 
 
Abstract          2 
Acknowledgements         3 
List of figures         6 
List of tables          7 
Chapter 1: Introduction        8 
   1.1 Ageing: mechanisms and theories      8 
         1.1.1 Basic biology and mechanisms of ageing 
         1.1.2 Evolutionary theories of ageing 
   1.2 From molecules to individuals: different levels of complexity   16 
   1.3 Theoretical approaches in ageing      20 
   1.4 Systems biology of ageing       23 
   1.5 Aims of thesis: overview of chapters      29 
         1.5.1 Pancreatic beta-cells mass regulation 
         1.5.2 Metabolic evolution and beta-cell antioxidant defences 
         1.5.3 Evolution of asymmetric damage segregation 
Chapter 2: An evolutionary model of intra-islet beta-cell dynamics  33 
   2.1 Introduction         33 
   2.2 Previous models          40 
   2.3 The model         42 
   2.4 Results          46 
   2.5 Discussion                54 
Chapter 3: Metabolic evolution and beta-cell antioxidant defences  58 
   3.1 Introduction         58 
         3.1.1 Beta-cells and glucose homeostasis 
         3.1.2 Reactive oxygen species: effects on beta-cells 
         3.1.3 Antioxidant defences in beta-cells versus other cell types 
         3.1.4 Beta-cell antioxidant defences: gender differences 
         3.1.5 Observations to be explained, questions to be answered 
   3.2 The hypothesis          66 
         3.2.1 The stress response and pregnancy 
         3.2.2 Hypothesis: ROS in beta-cells have an adaptive function in stress 
                  conditions including pregnancy 
         3.2.3 Summary of the hypothesis  
   3.3 Looking into the past: co-evolution or coincidence?    73 
3.4 Predictions         74 
3.5 Natural selection: master of trade-offs       75 
3.6 Clinical implications        79 
3.7 Beyond glucose homeostasis       81 
3.8 Robustness, homeostasis, and allostasis     82 
3.9 Appendix: a model for the regulatory role of ROS    83 
Chapter 4: A central role for stochasticity in evolution of asymmetric damage 
segregation: modelling and simulation      86 
   4.1 Introduction         86 
   4.2 Previous models         88 
   4.3 Structure of the model        89 
   4.4 Methods          91 
         4.4.1 Events and formulations 
5 
 
         4.4.2 Implementation and simulation 
         4.4.3 Regression analysis 
         4.4.4 Evaluation of fitness effects of asymmetry and their determinants 
   4.5 Results          98 
   4.6 Discussion         105 
         4.6.1 Asymmetry and trade-offs in resource allocations 
         4.6.2 Ecological aspects for the evolution of asymmetry 
         4.6.3 Costs of asymmetry 
         4.6.4 Future directions 
Chapter 5: An analytical model for the evolution of asymmetric damage 
segregation considering possible costs of asymmetry    115 
5.1 Introduction         115 
5.2 The model         117 
      5.2.1 Basic assumptions 
      5.2.2 Structure of the model 
5.3 Results          120 
      5.3.1 No degradation 
      5.3.2 With degradation 
      5.3.3 Costs of asymmetry 
5.4 Discussion         129 
      5.4.1 General implications of the results 
      5.4.2 Links to ageing 
      5.4.3 Transition to multicellularity 
5.5 Conclusions         134 
5.6 Appendix          135 
Chapter 6: Conclusions and future work        137 
Bibliography          142 
Appendix: publications         165 
 
 
 
 
 
 
 
 
 
 
6 
 
List of figures 
Figure 2.1. Steady state analysis when minmax r  (case (i)) 
Figure 2.2. Steady state analysis when 
s
Dc
r
'
minmaxmin    (case (i))  
Figure 2.3. Steady state analysis when 
s
Dc
r
'
minmax   (case (ii)) 
Figure 2.4. Steady state analysis for different values of maxr and s   
Figure 2.5. Steady state analysis for different patterns of relationship between 
maxr and s . 
Figure 2.6. Steady state value of beta-cell mass versus s  
Figure 3.1. Schematic histology of the pancreas 
Figure 3.2. Main elements of the glucose homeostatic system 
Figure 3.3. Glucose-induced insulin secretion in beta-cells and peripheral insulin-
induced glucose disposal  
Figure 3.4. Mean diurnal glucose concentrations in the third trimester 
Figure 3.5. The relation between stress and energy allocation 
Figure 3.6. The effect of ROS on glucose homeostasis 
Figure 4.1. Simulation results   
Figure 4.2. Increase of the asymmetric trait from rarity 
Figure 4.3. Fitness effects of asymmetry as measured by growth rates of genetically 
homogenous populations determined through simulations without mutations 
Figure 4.4. Steady state distribution of segregation strategies 
Figure 4.5. Schematic diagram showing various trade-offs affecting the evolution of 
asymmetry 
Figure 4.6. Experimental evidence for different levels of segregation asymmetry 
Figure 5.1. The stable steady state of the system with three typical trajectories 
7 
 
Figure 5.2. Fundamental relationships stemming from physiological trade-offs 
Figure 5.3. The condition in which symmetry offers its highest possible fitness 
advantage 
Figure 5.4. The effects of particle number and segregation fidelity on damage 
variation 
Figure 5.5. Comparison between symmetry and asymmetry for the relation between 
maintenance investments and fundamental properties of the system 
 
List of tables 
Table 2.1. Notations and definitions used in the model 
Table 3.1. Summary of the changes that occur in glucose homeostasis in pregnancy 
Table 3.2. The proposed evolutionary history of beta-cells  
Table 4.1. Events and their hazard functions for one cell 
 
 
 
 
 
 
 
 
 
 
8 
 
Chapter 1: Introduction 
1.1 Ageing: mechanisms and theories 
1.1.1 Basic biology and mechanisms of ageing  
An accepted definition of ageing is the deterioration of tissues, cells, and cellular 
substructures over time that is manifested as an increase in intrinsic mortality and a 
decrease in reproductive rate (Rose 1991). In order to survive and reproduce, every 
organism needs to protect itself against sources of damage and repair any damage that 
occurs to its physical structure and physiological mechanisms. There are several 
sources of damage which can be broadly classified as extrinsic or intrinsic. Extrinsic 
sources originate from interaction with the environment and include factors such as 
heat, cold, radiation, infection, toxins and predation. Levels of extrinsic factors are 
known to correlate with longevity between and within species. Comparative studies of 
senescence in birds and mammals suggest that the rate of senescence has been 
modified by evolution in response to the potential life span allowed by extrinsic 
mortality factors (Ricklefs 2010). Within species differences in lifespan are apparent 
between populations that have been subject to different levels of protection, for 
example individuals of mainland populations are generally shorter lived than island 
populations subject to lower levels of predation (Kirkwood and Austad 2000). 
Intrinsic damage consists of any damage that occurs as a result of intra-organismal 
biological processes (Ricklefs 1998). A well-known and highly conserved process is 
free oxygen radical production as a result of oxidative phosphorylation and glucose 
metabolism (Harman 1956). If not properly neutralized, these radicals can cause 
significant cellular damage and are widely considered a principal mediator of ageing 
(Harman 1956, Paiva et al. 2005; Harman 2009). Thinking of biological entities as 
physicochemical systems with certain turnover rates, intrinsic damage also includes 
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the damage that occurs as a result of stochastic failure of one or more elements of a 
complex system over time (Gavrilov & Gavrilova 2004, 2006). Damage, regardless of 
its source, accumulates within the organism because with time the organism‟s 
protective mechanisms deteriorate and/or repair mechanisms lose their functionality 
(Hayflick 1998). In particular, age-related impairment of DNA base excision repair 
pathways has been shown to have a fundamental role in age-related 
neurodegenerative diseases such as Alzheimer's disease (Coppedè & Migliore 2010).    
 
Protective mechanisms include simply avoiding the source of damage or attempting to 
remove the source. The immune system is the main organism-level protective system. 
At the intracellular level, the antioxidant system is a major protective investment that 
reduces the threat posed by reactive oxygen species (see below). Other such systems 
are toxin removal systems whose importance in ageing has been highlighted (Gems & 
McElwee 2005). Repair of damage that does occur operates at all biological levels: at 
the molecular level DNA damage is repaired by several mechanisms including base 
excision repair for the replacement of base lesions - the most common damage to 
DNA, nuclear excision repair, homologous and non-homologous end joining; damage 
to proteins is addressed with turnover involving proteases and the proteosome; 
damaged cellular components such as mitochondria are removed by processes such as 
autophagy and damage to cells by digestion and lysis by macrophages. The final 
resort, when all other less costly repair mechanisms fail, is death and silent 
disappearance of the cell/organism by well orchestrated processes such as apoptosis, 
autophagy or cellular senescence. Whether or not senescence and death are adaptive 
and a last resort repair mechanism, is still debated (Bergamini 2006; Kültz 2005).   
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Inevitably damage does occur and age-related increases in somatic mutation and DNA 
damage (Gensler & Bernstein 1981; Promislow 1994), telomere loss (Kim et al. 
2002), mitochondrial DNA mutations resulting in impaired bioenergenesis (Wallace 
1999), and impairment of the protein degradation machinery resulting in damaged 
protein accumulation (Terman & Brunk 2004; Carrard et al. 2002; Soti & Csermely 
2003) are some of the mechanisms that may act individually or in concert to cause 
ageing (Kirkwood et al. 2003). Sources of damage such as oxidative stress may cause 
multiple types of damage including somatic mutation and DNA damage, and telomere 
loss, which is a good example of two or more mechanisms acting together (von 
Zglinicki 2002). Since many of the above mechanisms exist in unicellular and 
multicellular organisms, as well as eukaryotes and prokaryotes (Ackermann et al. 
2003; Stewart et al. 2005), it is not surprising that ageing is universal in all kingdoms 
of life. 
 
In addition to the oxididative stress theory of ageing other attempts have been made to 
provide a unifying framework to embody the molecular mechanisms of ageing. The 
network theory of ageing proposed by Kowald and Kirkwood in 1994, was an early 
systems approach linking multiple molecular mechanisms. It describes the reactions 
of free radicals, antioxidants and proteolytic enzymes, with the error propagation 
loops within the cellular translation machinery. This theory predicts that more 
investment in repair and maintenance is positively correlated with longevity. It 
supports the prediction of the oxidative theory of ageing that increased reactive 
oxygen species (ROS) production and/or inadequate antioxidant defence can 
destabilise an otherwise stable translation system. The model also supports the idea 
that caloric restriction delays ageing via a reduction of ROS generation (Kowald & 
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Kirkwood 1994). The theory is built upon the idea that multiple ageing mechanisms 
act in parallel (Kirkwood & Kowald 1997). Support for this theory comes from 
empirical results showing an increase in the fraction of inactive proteins with age, a 
significant rise in protein half-life with age, an increase in the amount of damaged 
mitochondria with age, and a drop in the energy generation per mitochondrion with 
age (Kowald & Kirkwood 1996). As a second example, a thermodynamics view of 
ageing states that ageing is the result of a decreased capacity of biological systems to 
degrade energy and maintain sufficient specific entropy production. According to this 
school of thought, senescence is a steady state characterised by two major features: a 
higher level of damage and a lower global biochemical activity (Toussaint et al. 1991; 
Toussaint et al. 1995; Toussaint et al. 2002). A number of predictions of this idea 
have been tested experimentally (Toussaint et al. 1992).      
  
1.1.2 Evolutionary theories of ageing 
There are several theories that focus on evolutionary origins of ageing (Kirkwood 
2008). If ageing is controlled by genes, then it could evolve like any other genetically 
regulated phenotype. Several mutations are known to accelerate or prevent ageing. 
The first empirical support for the idea of ageing being seen and acted upon by natural 
selection came from single gene mutations that significantly increase life span in the 
nematode Caenorhabditis elegans (Friedman & Johnson 1988). More longevity genes 
are being discovered. Very recently, it was shown that an isoform of DAF16 (FOXO 
homologue), a major target of the insulin signalling pathway, regulates longevity 
(Kwon et al. 2010). There are theories that consider ageing as a programmed 
phenomenon and there are others that do not. The altruistic theory of ageing from the 
former category and the mutation accumulation theory, antagonistic pleiotropy, the 
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disposable soma theory, and the network theory of ageing from the latter category will 
be briefly discussed here.  
 
Altruistic ageing: This theory suggests that organisms have a program that has 
evolved specifically to cause ageing and the reason for the evolution of such an 
apparently counterintuitive program by which the organisms gives up survival is 
because ageing and death can increase one‟s inclusive fitness (i.e. kin selection), 
group fitness, or population fitness. The support for this theory is mainly from recent 
experiments in yeast Saccharomyces cerevisiae in which ageing seems to be an 
adaptive process that benefits small subpopulations of closely related mutants through 
kin selection (Herker et al. 2004; Fabrizio et al. 2004). It should be noted that 
Saccharomyces cerevisiae live as clonal populations, satisfying the main requirement 
for kin selection to act (Hamilton 1964). Proposed examples of ageing-related benefits 
at the group or population level include population stabilisation, enhanced genetic 
diversity, shortening of the effective generation cycle, and acceleration of the pace of 
adaptation (Fabrizio et al. 2004). In particular, altruistic suicide is best known in the 
context of programmed cell death (PCD) in multicellular individuals, which is 
understood as an adaptive process that contributes to the development and 
functionality of the organism. My colleagues and I have recently argued that it is not 
straightforward to import the paradigm of altruistic cell death from multicellular 
organisms to explain active death in unicellular lineages (for a complete review see 
Nedelcu et al. 2010). Active death could be co-opted into an altruistic trait under 
conditions in which kin/group selection can act, but such conditions might not have 
been sufficiently common to promote the early evolution of ageing/suicide as an 
altruistic trait. 
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Mutation accumulation: This theory, proposed by Medawar (Medawar 1952), is based 
on the observation that the force of natural selection decreases in old age due to the 
enhanced value of offspring born in early life and also to the inevitable loss of 
individuals in late life. Consequently, mutations with detrimental late effects will be 
neutral to natural selection and will not be actively protected against, ageing ensuing 
as the inevitable consequence (Partridge & Gems 2002).  
 
A number of attempts have been made to test the predictions of the mutation 
accumulation theory with mixed success. For example, the deleterious effects of 
inbreeding are expected to increase with age under mutation accumulation, but not 
under antagonistic pleiotropy (see below). Snoke and Prominslow (2003) carried out a 
large-scale quantitative genetic analysis of age-specific mortality and fertility in virgin 
male Drosophila melanogaster which was consistent with this prediction. The theory 
also predicts an age-related increase in additive genetic variance for fitness traits. 
Going against this prediction, genetic analysis of mortality in D. melanogaster showed 
that mortality curves of different genotypes are roughly parallel (Prominslow et al. 
1996). Consistent with the prediction of the mutation accumulation theory, the genetic 
variability of mortality in male D. melanogaster increases greatly at very late ages 
(Hughes & Charlesworth 1994).  
 
Antagonistic pleiotropy: this theory proposed by Williams (Williams 1957) and later 
formulated mathematically by Charlesworth (Charlesworth 1994), suggests that there 
are genes with beneficial effects (for reproduction or survival) early in life and with 
deleterious effects at old ages. Natural selection favours these genes because of their 
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early effects which contribute proportionally more to fitness. Ageing ensues as an 
inevitable consequence of the late effects. The trade-off between reproduction and 
longevity is a major prediction of this theory. While the mutation accumulation theory 
is based on mutations that occur randomly and are not passed on across generations 
(because they occur late in life), antagonistic pleiotropy assumes genes (with 
pleiotropic effects) that are under the force of natural selection (because of their early 
beneficial effects) and are actively maintained in the population (Le Bourg 2001).  
Williams suggested, as an example, that there may be a gene that increases the 
fixation of calcium in bones. Such a gene may have positive effects at a young age 
(decreasing the risk of bone fracture and subsequent death), but negative effects in 
later life, because of increased risk of osteoarthritis due to excessive calcification. 
This automatically creates a trade-off between early positive effects and late negative 
effects. In the wild, the negative effects of such a gene would be hidden from natural 
selection, because most animals would die long before the negative effects of the gene 
could be observed. In protected laboratory experiments, however, both positive and 
negative effects may be demonstrated. It was recently suggested that p53 represents a 
case of antagonistic pleiotropy (Ungewitter & Scrable 2009). This tumor suppressor 
confers protection against cancer (and death) by interrupting the abnormal 
proliferation of cells. The same effect on normal stem cells, however, can lead to 
impaired tissue homeostasis and accelerated ageing. If it could be shown that the 
deleterious effects of p53 on ageing are not attributable to genes that can modify p53 
activity but are evolving independently, then we could consider p53 as an example for 
antagonistic pleiotropy. Finally, Charlesworth (1996) suggests that the involvement of 
both polymorphic alleles and rare mutations in pathogenesis of Alzheimer‟s disease is 
consistent with both mutation accumulation and antagonistic pleiotropy theories.  
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Disposable soma: This theory was proposed initially by Kirkwood and later 
developed with Holliday (Kirkwood 1977; Kirkwood & Holliday 1979) is built upon 
the concept of resource allocation optimisation. Resources are always limited in 
nature and thus only finite amounts can be allocated to physiological functions such 
as growth, reproduction and maintenance. The result is that trade-offs exist where for 
example more investment in reproduction and growth will retract from repair 
mechanisms and maintenance of soma. The function of the soma is to support the 
organism through its expected (not maximal) life span, which is not long in the wild 
given the extrinsic hazards that are the most common cause of death. Limited 
investment in maintenance and repair, augmented by a pressure to reproduce before 
the accumulated risk of death reaches critical levels, makes the organism prone to 
ageing if it lives long enough (Kirkwood 1977; Kirkwood & Austad 2000). The 
disposable soma theory provides a mechanism for the reproduction-longevity trade-
off and provides a complementary theory based in physiology to the former two 
theories based in genetics. Several lines of evidence support the disposable soma 
theory, the most important of which is the observation that longer-lived mammalian 
species tend to have higher levels of cellular protection against stress. Kapahi et al 
(1999) compared cellular resistance of primary skin fibroblasts from eight mammalian 
species with a range of life spans. Cell survival was measured after exposure to a 
variety of oxidative and non-oxidative stresses and significant positive correlations 
were found between cellular resistance and longevity. An important part of cellular 
maintenance is prevention and repair of DNA damage. Poly(ADP-ribose) 
polymerases (PARPs) are involved in DNA base-excision repair and other repair 
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pathways. Mammalian longevity has been correlated in a number of studies with the 
abundance and activity of this maintenance system (Beneke & Bürkle 2007).  
 
1.2 From molecules to individuals: different levels of complexity 
Ageing can be studied at different levels. At the population level, one may study 
ageing by looking at actuarial life contingency tables and mortality curves (Gompertz 
1825). The Gompertz law provides a relationship between mortality rates and the 
chronological age. It does not, however, deal with underlying mechanisms of ageing. 
Attempts have been made to explain the exponential growth of mortality that is 
suggested by Gompertz law by lower level events and processes. For example, it has 
been shown that a simple model of death as a result of an exponentially rare escape of 
abnormal cells from immunological removal translates into mortality curves similar in 
shape to those predicted by Gompertz law (Shklovskii 2005). Another curious 
example of such between-level links concerns the progressive accumulation of 
insoluble cross-linked proteins with age. These aggregates are known to impede 
various cellular functions and the slope of the Gompertz curve has been suggested to 
be a measure of the rate of insoluble protein accumulation (Hallén 2008).  
 
One can also focus on sub-individual levels, i.e. organ/tissue ageing. This is important 
as the effect of ageing of different tissues on whole organism ageing is most probably 
not linear, even though it is possibly cumulative. For example, the rate of 
accumulation of DNA damage in liver and kidney cells with age in mice is inversely 
proportional to maximum achievable lifespan, suggesting a complex relationship 
between organismal and organ ageing (Su et al. 1984). In spite of some recent 
comparative attempts (Wang et al. 2009), it is not clear how the ageing “state” of the 
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organism can be represented by a function of the ageing states of its individual 
tissues/organs. The transcriptional profiles of ageing in Drosophila melanogaster 
across seven tissues was investigated recently and the age-related genes showed clear 
tissue-specific patterns (Zhan et al. 2007). AGEMAP, a gene expression database 
recently developed for ageing in mice, describes expression changes for more than 
9,000 genes in 16 mouse tissues as a function of chronological age. According to this 
database, some tissues have a more significant contribution than others to organismal 
decline. Tissues were classified into one of three ageing processes: (1) a pattern 
common to neural tissues, (2) a pattern for vascular tissues, and (3) a pattern for 
steroid-responsive tissues (Zahn et al. 2007). Databases like AGEMAP will hopefully 
make it possible in future to describe the ageing state of the organism as a function, 
no matter how complex, of the ageing state of its tissues.  
 
Most studies of mechanisms of ageing are focused at the level of the cell or below. 
With advanced molecular techniques, it is now feasible to dissect signalling pathways 
to their individual molecular components and study the role of each in the ageing 
process. One of the most important challenges in this approach concerns the 
involvement of one pathway, or part of that the pathway, in more than one cellular 
process. As a result, in order to see the role of a given molecule in ageing, one would 
need sufficient amount of knowledge about the effects of that molecule on other 
processes. The P53 pathway, for example, is known to be involved in several 
important cellular processes. It protects mammalian cells both from cancer and 
ageing. However, constitutionally active P53 can also induce ageing (Matheu et al. 
2008). Such apparently contradictory observations may partly be explained by the 
overlap between different pathways and cellular processes. Clearly most if not all 
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molecules act in complex networks rather than pathways. The same issue applies 
when one wants to gain insight into evolutionary origins of ageing from a 
cellular/molecular perspective. Ageing has been proposed to be an inevitable and 
accidental by-product of selection acting on other processes (Kroemer 1997; Ameisen 
2004). Alternatively, it can be a direct result of natural selection acting on the ageing 
process itself as an adaptive process (see evolutionary theories of ageing above).  
 
Metabolic pathways are now recognized as regulators of longevity. This is consistent 
with the disposable soma theory of ageing, which considers resource allocation trade-
offs resulting from limited resource availability as the root of ageing. Most of central 
metabolic pathways are somehow involved in nutrition sensing (insulin/insulin-like 
signalling pathway) and eventually affect cellular maintenance systems (Partridge & 
Gems 2002). Genes that regulate these pathways include those affecting insulin 
signalling (e.g. daf-2 in C. elegans) and those coding proteins known as sirtuins 
(Longo & Kennedy 2006). Dietary restriction experiments, in which a restricted 
caloric intake is imposed on the animal, exert many of their effects through directional 
manipulation of metabolic pathways. When nutrients are scarce, C. elegans switches 
to an alternative developmental pathway and generates stress-resistant, long-lived 
forms known as dauer larva (Riddle et al. 1981). The fact that metabolic pathways are 
involved in the ageing process and longevity is without doubt. However, their 
importance under natural conditions and how longevity may be enhanced through 
harmless manipulations of such pathways in a given organism under certain 
environmental conditions is a matter of debate (Shanley & Kirkwood 2000). Taken 
together, as one moves from a higher level approach (e.g. population) to lower levels 
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(e.g. molecules), more insight is gained into detailed mechanisms at the cost of a 
sacrifice in evolutionary understanding of the ageing process.  
 
As complex systems, biological systems have multiple levels. Molecules are at a 
lower level than cells because a cell can be broken apart into molecules but not vice 
versa. Three main approaches to dealing with different biological levels may be 
recognised: (i) top-down: starts from organisms and organs down to molecules, (ii) 
bottom-up: starts from molecules and attempts to integrate them in pathways, then in 
organelles, cells, tissues and so on to organs and organisms, (iii) middle-out approach: 
starts at any level for which there is sufficient understanding to identify a causal 
chain. When a satisfying interpretation of the available data has been achieved at the 
chosen level, the investigation would move out to other levels. The optimal approach, 
as claimed in this thesis, is one that bridges between approaches at different levels and 
brings them all together in a unified framework. This is a key aim of systems biology 
(Kirkwood 2008). 
 
Also, multiple scales can be identified in biological systems. The functions exhibited 
by a complex system can be local or global, and the degree of locality may be 
quantified. For example, vision occurs at a larger scale than transmission of visual 
electric signals from the eye to the brain. Several processes of the latter type occur on 
a smaller scale to make vision (a larger scale phenomenon) possible. Vision is the 
product of communication between several neurons and their signalling. Ironically, 
the organism “sees” but its neurons do not. In their recent review of the cardiac 
Physiome project, Bassingthwaighte et al (2009) discuss three important reasons why 
multiscale analysis is an essential component of systems biology. Firstly, complex 
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systems (e.g. heart) are inevitably multiscalar, composed of elements of diverse 
nature, constructed spatially in a hierarchical fashion. Not only do the components 
determine the behaviour of the system as a whole, but also the system exerts certain 
constraints on the behaviour of its components. A middle-out approach seems 
appropriate in this situation where a single level of causation cannot be easily 
assumed. Secondly, in systems analysis, one needs to be able to discover at which 
level each function is integrated. For example, a cardiac rhythm does not make any 
sense at any level below the cell. On the other hand, ventricular fibrillation is a 
function integrated at the level of the tissue and even of the whole organ. And the 
pump function is an organ-level property. As the authors mention, higher-level 
emergent properties “do not „emerge‟ blindly from the molecular events; they were 
originally guided by natural selection and have become hard-wired into the system”. 
The third reason concerns the genetic differential effect problem. This concept refers 
to the fact that most gene-level events (e.g. mutations) do not have phenotypic effects. 
Biological systems are robust, meaning that genetic events are effectively buffered by 
back-up systems. Moreover, phenotypic effects of mutations “reveal simply the 
consequences of the difference at the genetic level; they do not reveal all the effects of 
that gene that are common to both the wild and mutated gene” (Bassingthwaighte et al 
2009).  
 
1.3    Theoretical approaches in ageing 
Theory and experiment have been an inseparable pair since biology was born as a 
science. Even in the very past, when empirical approaches were confined mostly to 
pure observation without intervention, and mathematics was in its early ages, the 
combination of theory and experiment was not nonexistent. Ironically, the philosophy 
21 
 
by which observations are explained and further extended to yield more general 
statements can be thought as a parallel theoretical tool. With the advent of more 
sophisticated experimental and theoretical tools, the theory/experiment tool gained a 
more solid and fruitful shape. Let us briefly review some examples of this pathway to 
complexity.  
 
Gompertz law, introduced above, was one of the earliest attempts to explain ageing in 
a generic theoretical framework (Gompertz 1825). Many more attempts have been 
made ever since to tackle this complex phenomenon with and without explicit 
connection to underlying mechanisms. Hamilton (1966, 1996) used a theoretical 
approach to quantify the force of selection and show that senescence is inevitable, i.e. 
survival and fertility decline with age. He derived expressions for the change in 
fitness with respect to age-specific mutations. This result has been widely used in the 
evolutionary theory of ageing ever since. An important assumption behind Hamilton‟s 
result is the additivity of the effects of mutations on mortality and feritiliy. Not known 
at the time, the results of several demographic and epidemiological analyses of risk 
factors have found that proportional effects are more common than additive effects. 
Empirical results of Promislow and Tatar (1998) are an important example of such 
studies. Alternative indicators may therefore be derived that can result, in some 
circumstances and over some age ranges, in an increasing force of selection with age. 
As mentioned, Hamilton‟s well-known conclusion depends on how we define the 
association between age and the indicators of the model. Hamilton's indicators are 
decreasing functions of age. Baudisch (2005) and Vaupel et al (2004) have used 
alternative parameterizations of mutational effects to derive plausible indicators that 
can increase with age.    
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Theoretical approaches addressing molecular mechanisms can be arbitrarily classified 
into two broad categories of bioinformatics and dynamical modelling. 
Bioinformaticians use high throughput data (genomics, transcriptomics, proteomics, 
metabolomics, etc) to gain insight into the links between genes, proteins, and modules 
(Raghothama et al. 2005). Both causal (e.g. positive and negative feedback loops) and 
solely correlational relationships (co-expression of a number of genes) may be sought 
using this approach (de Magalhães & Toussaint 2004). Reverse engineering (defined 
as “the process of analyzing a subject system to identify the system‟s components and 
their interrelationships and create representations of the system in another form or at a 
higher level of abstraction” (Chikofsky & Cross 1990)) of ageing is in theory possible 
(D'haeseleer et al. 2000), but the number of experiments required to fully understand 
ageing is at present beyond our technology (Wagner 2001; Krupa 2002). In a complex 
system such as the ageing molecular network, in which every element depends on at 
most K other elements, the number of experiments required to find the causal network 
depends exponentially on K, emphasising the importance of the interactions between 
network elements (Krupa 2002). 
 
Dynamical modeling can further be divided to deterministic and stochastic modeling 
techniques (Yashin et al. 2007; Portugal et al. 2008). Deterministic models are based 
on ordinary or partial differential equations that approximate the collective behaviour 
of a large number of units (molecules, cells, etc) in a deterministic way. If the 
structure of the model, the value of the parameters involved in the model, and the 
initial conditions are fully known, one can predict the behaviour of the model with 
complete accuracy. Population genetics models, for example, frequently use matrix 
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algebra and age-specific transitions embedded within a transition matrix to model the 
evolution of a population over time. Work in this area has benefited from the 
population genetics toolkit for studying ageing developed by Charlesworth (1980). In 
stochastic models, the extrinsic (e.g. environmental effects) and intrinsic (e.g. low 
number of molecules) noise are taken into account and introduce variability in the 
behaviour of the model. Typically, several simulations are run using similar parameter 
values and initial conditions and the average of the simulations is regarded as the 
model outcome. New methods such as cellular automata (agent-based simulation 
technique) have enabled us to study spatially structured systems. Using the latter 
technique, one can monitor the behaviour of individual elements over time. Cellular 
automata models may be deterministic or stochastic.  
 
Modeling can be used in ageing sciences at different levels, from populations to 
molecules. In this thesis, we will see examples of deterministic and stochastic models 
at different levels.     
 
1.4     Systems biology of ageing  
As it is hard to come up with a single definition of systems biology, it is also difficult 
to summarize what systems biology of ageing is expected to yield. A practical 
definition, provided by Wikipedia (http://en.wikipedia.org/wiki/Systems_biology), 
suggests systems biology as a biology-based interdisciplinary study field that focuses 
on complex interactions in biological systems, using a new perspective (holism 
instead of reduction). Kirkwood (2008) proposes four categorically different 
definitions for systems biology:  
24 
 
(i) A field of study “involving the quantitative analysis of interactions 
between elements of biological systems” 
(ii) A set of multidisciplinary methodologies focusing on “cycles of iteration 
between empiricism and theoretical modelling. 
(iii) An integrative approach as an alternative to the traditional reductionist 
approach.  
(iv) An organizational phenomenon that brings together scientists from diverse 
disciplinary backgrounds.  
 
In a complex system with several layers of interactions between components, the 
behaviour of the system as a whole may not always be a linear sum of the behaviour 
of the components. “Emergent properties” are systems-level, complex behaviours that 
emerge from relatively simple interactions between lower level components. One of 
the targets of systems biology is to investigate how such emergent properties relate to 
the features of lower level units and their interactions. Molecular systems biology, for 
example, focuses on networks that originate from interconnection of genes, proteins 
and metabolites whose dynamic interactions generate, as an emergent property of the 
system, the corresponding function. A molecular systems biologist is interested in 
intracellular biochemical parameters, such as the expression level of gene products or 
the affinity between two or more proteins that must have a permissible range that 
gives robustness against perturbations to the system. Identification of such parameters 
in different organisms and systems is an interesting field of systems biology research. 
One recent example concerns the yeast G1-to-S transition network (Alberghina et al. 
2009). In this particular example, different emergent properties have been shown to be 
generated from the same network by changing the strength of its interactions, not only 
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by altering expression level, but also through mono and multi-site 
phosphorylation/dephosphorylation. Noise and stochasticity make predictions along 
the pathway from lower to higher level behaviour less trivial and more challenging, 
and we know noise and stochasticity are inherent in all biological systems.  
 
Subcellular components age and lose their functionalities; cells age as a result, 
followed by tissues and organs. The individual, our traditional evolutionary unit, will 
be affected by all these ageing processes and eventually dies. Ultimately, groups, 
populations, and the species will be affected. How much do we know about 
mechanistic details of ageing at the lower levels? The answer is we know a fair 
amount. However, known details are extremely scattered and using commonly used 
tools cannot conveniently be merged into a unifying theory. At least two important 
factors play a role here. The first factor is the numerical complexity of the involved 
mechanisms. Thinking of an organism as an extremely complex machine composed of 
many small parts, each prone to various sources of insult and failure, there will be an 
enormous number of ways the whole system may deteriorate with time as a result of 
injury to its parts. What makes the situation even more complicated is the cumulative 
nature of damage. Apart from damages that are incompatible with life (e.g. severe 
karyotypic changes that kill the organism early in life), most types of damage (e.g. 
oxidative damage) accumulate with time. Not a single unit of damage can be 
identified as the cause of system failure in most instances. Therefore, we are dealing 
with an additional dimension: time. Do we know how subcellular ageing is related to 
population level phenomena? We are currently far from it. The second factor is 
stochasticity. In the case that the mechanisms follow deterministic rules, one could, at 
least theoretically, analyse all possibilities and potentially come up with a 
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comprehensive explanation, no matter how complicated it would be. However, there 
is intrinsic stochasticity in nearly all ageing mechanisms. This stochasticity creates 
variability from molecule to molecule, cell to cell, and individual to individual (Finch 
& Kirkwood 2000). The combination of multiplicity and stochasticity makes any non-
integrative approach deficient in some respect.  
 
Evolution is now regarded an inseparable part of biology. When it comes to the 
individual-level and higher, evolutionary arguments become increasingly more 
powerful. Thinking of reproductive success as the ultimate goal of natural selection, 
all cellular and subcellular processes may be thought of as an outcome of selection to 
enhance reproductive success, unless certain things go beyond the ability of natural 
selection. Ageing is no exception. Do repair and maintenance processes stop 
functioning at their maximal capacity, not because they wear and tear, but because the 
reproductive success of the evolutionary unit demands so (Mitteldorf 2010)? Whether 
optimal resource allocation (as proposed by the disposable some theory of ageing) is 
the root of ageing is an important question. The major issue, however, applies to a 
larger scale and supersedes detailed mechanisms. The concept of optimal resource 
allocation may not be required to explain the evolutionary advantageous deceleration 
in maintenance/repair system functions. Ideas like this are what I will work on in most 
parts of this thesis. The role of systems biology in the question at hand is manifest 
given that we will be dealing with biochemical processes at the subcellular level, cell-
cell interactions, whole body homeostasis, and reproductive fitness of the organism.  
 
Let us review a few examples of recent advancements in systems biology of ageing 
and age-related diseases. Boudovsky et al (2007) made the first attempt towards 
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constructing a longevity network based on protein-protein interaction data (329 
longevity-associated proteins). The network was found to be scale-free with an 
extremely high contribution of hubs (proteins with the highest number of partners) to 
the network connectivity. Most hubs tuned out to be related to at least one major age-
related disease (e.g. atherosclerosis, cancer, Alzheimer‟s disease). Human age-related 
disease proteins and longevity-associated proteins together with their direct binding 
partners form scale-free networks. Signalling proteins are abundant in these networks. 
Interestingly, pathways associated with cell-cell and cell-extracellular matrix 
interactions and focal adhesion are overrepresented (Wolfson et al. 2009). An 
extracellular age-related network comprising both extracellular proteins and 
glycosaminoglycans was built recently. Among overrepresented biological processes 
in this network, „„response to wounding‟‟ and „„tissue regeneration‟‟ were related to 
extracellular events, which are impaired upon ageing (Chautard et al. 2010).  
 
Recent systems biology studies have identified an intricate relationship between the 
ageing process and genetic diseases. A human disease-ageing network was 
constructed to study the relationship among ageing genes and genetic disease genes 
(Wang et al. 2009). A total of 1,438 genes were included. Protein-protein interactions, 
disease-gene associations, ageing-gene associations, and physiological genetic disease 
classification information were integrated into a single comprehensive network. It was 
found that disease genes are much closer to ageing genes than expected by chance. 
The authors suggested a novel classification of diseases according to their 
relationships with ageing. Age-related diseases (i.e. those with statistically significant 
overlapping with ageing: cancer, neurological diseases, endocrine diseases, nutritional 
disease, and developmental disease) turned out to be in a central position of the 
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protein-protein interaction network whereas non-age related disease genes had more 
peripheral positions. Centrality was quantified by a network property called mean 
closeness centrality. An important result of this study was that ageing genes make a 
significant contribution to associations among diseases, especially among type I 
diseases. The authors used this result to address the well-known question of why 
natural selection has not been able to remove all disease genes over the course of 
millions of years of evolution. Since the force of natural selection declines with age 
(Kirkwood 2002), by remaining close to ageing genes, disease genes can avoid 
negative selection. Interestingly, cancer genes did not make a significant contribution 
to associations among most of diseases by the closeness analysis in protein-protein 
interaction network.  
 
An interesting example of how systems biology may cause a substantial improvement 
in our understanding of the ageing process can be demonstrated by theories of 
menopause (Rashidi & Shanley 2009). A long postreproductive lifespan is a 
characteristic feature in the life history of human females. The mother and 
grandmother hypotheses, the most prominent evolutionary theories of menopause, 
propose that the altriciality of human infants, early age of weaning, high maternal 
mortality, the supportive role of grandmothers in childcare, and intergroup female 
transfers made an early cessation of reproduction advantageous in human females. On 
the other hand, ovarian exhaustion (the progressive loss of oocytes beginning before 
birth) has been long recognised as the proximate cause of menopause, without much 
attention to fine details. Unfortunately, our proximate knowledge about menopause is 
severely detached from our evolutionary explanations. Assuming that menopause is 
the outcome of an evolutionary process, and is mechanistically caused by ovarian 
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exhaustion, one would like to see how the two processes are linked through 
evolutionary time. Most efforts have to date been focused on fitting curves to the few 
data available, rather than trying to explain why the dynamics of oocyte depletion 
follows a particular pattern. A systems biology approach should ideally link together 
the ovulation physiology, ovarian dynamics, and life history. In a recent review, we 
mention the outstanding issues and how they may be overcome using newer tools 
(Rashidi & Shanley 2009).  
 
In brief, ageing is a process that takes place at the systems level, and is closely 
connected to other systems-level processes such as cell death pathways and diseases. 
The phenomenology of the ageing process follows a segmental and mosaic 
distribution, as all tissues and organs do age at different rate. Therefore, 
understanding what happens to the organism as suborganismal processes go on during 
the ageing process requires knowledge about the structure and dynamics of the 
complex interaction network that binds all the involved components together. The 
process of ageing cannot be satisfactorily understood without taking into 
consideration other important phenomena such as age-related diseases, genetic 
diseases, and cell death pathways. 
  
1.5       Aims of thesis: overview of chapters 
Unicellular organisms age, as do we humans. There is a high level of evolutionary 
conservation along the tree of life in the events leading to ageing. This provides an 
exceptional opportunity to study simpler systems and extend the results to more 
complex forms of life. There is a large amount of data available on ageing in 
organisms and suborganismal entities of varying levels of complexity. However, there 
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is a shortage of attempts in coherently explaining the rapidly growing data that 
emerges from various empirical fields such as cellular and molecular biology. A 
systems-level approach is required to bridge the gap between different levels. Also, 
given the evolutionary nature of the question at hand, a successful hypothesis needs to 
be able to account for evolutionary considerations. In the following projects, I take a 
theoretical approach and try to explain a number of aspects of ageing from a systems-
level perspective in an evolutionary context. Two common themes can be identified in 
each chapter: (i) a systems-level approach consisting of data mining, assembling data, 
and hypothesis generation, and (ii) evolutionary thinking. Case studies will range 
from fundamentals of ageing (e.g. asymmetric damage segregation) to consequences 
of ageing (e.g. type 2 diabetes).   
 
1.5.1    Pancreatic beta-cell mass regulation 
Beta-cells are at the core of pancreas endocrine physiology. By secreting insulin in 
response to rises in plasma glucose concentrations, they effectively maintain short-
term glucose homeostasis. Although short-term homeostasis is achieved by higher 
average insulin secretion rates per beta-cell without significant changes in the beta-
cell mass (number), regulation of the mass is crucial in the long-term (Bonner-Weir 
2000; Kasuga 2006; Bernard et al. 1999). Disturbances in this process seem to be 
responsible for chronic disease states such as glucose intolerance and diabetes 
(Laybutt et al. 2003; Bouwens & Rooman 2005; Rhodes 2005). Mechanisms of long-
term beta-cell mass regulation have not been identified completely, hindered in part 
by the difficulty of in-vivo measurement but also by a lack of sufficient mathematical 
modelling studies. The available models (Finegood et al. 1995; Topp et al. 2000) have 
made significant contributions but recent experimental observations together with an 
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increase in our mechanistic understanding render them in need of revision. 
Considering that type 2 diabetes is an age-dependent disease, I develop a 
deterministic, analytical model of beta-cell mass regulation which takes into account 
recent discoveries in pancreas endocrine physiology.  
 
1.5.2    Metabolic evolution and beta-cell antioxidant defences 
Pancreatic beta-cells are unique among other cells in possessing an extremely weak 
antioxidant defense system (Grankvist et al. 1981; Lenzen et al. 1996; Malaisse et al. 
1982; Tiedge et al. 1997; Zhang et al. 1995). Furthermore, beta-cell defenses against 
oxidative stress in both mice and humans are weaker in females than in males 
(Cornelius et al. 1993; Tonooka et al. 2007). These observations need an evolutionary 
explanation given that oxidative stress in beta-cells has an important contribution to 
the pathogenesis of type 2 diabetes (Tanaka et al. 2002; Chang-Chen et al. 2008). 
Using a systems-level approach to the glucose homeostatic system and beta-cell 
physiology, I provide a satisfactory evolutionary explanation for the puzzle. The 
hypothesis involves interesting connections between physiology and ecology, 
pregnancy, brain evolution, mammalian evolution and stress response evolution. Both 
micro- and macroevolutionary aspects of the glucose homeostatic system are covered 
by the hypothesis.   
 
1.5.3 Evolution of asymmetric damage segregation 
Ageing is ubiquitous in all kingdoms of life, hence the origins of ageing may well be 
sought in unicellular organisms. Asymmetric segregation of irreversibly damaged 
cytoplasmic macromolecules has been shown to be a major contributor to unicellular 
ageing (Ackermann et al. 2003). This is because with symmetric distribution of 
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damage at mitosis, the population either vanishes (if the rate of damage accumulation 
is sufficiently high) or never senesces (if the rate of damage accumulation is 
sufficiently low). With asymmetry, we can distinguish between an aged daughter cell 
(the one which inherited more damage) and a young one (the one which inherited less 
damage) (Ackermann et al. 2007). Irreversible protein aggregates cannot be handled 
by the cell and are transferred across generations if their carriers survive to the time of 
mitosis. The segregation strategy, however, seems to fit a continuum, ranging from 
near complete symmetry (Minois et al. 2006) to near complete asymmetry (Aguilaniu 
et al. 2003), rather than an all-or-none pattern. Furthermore, some single-celled 
organisms can change their segregation strategy in response to environmental changes 
(Aguilaniu et al. 2003). Our knowledge about the proximate mechanisms of 
asymmetric segregation has substantially improved over the last few years, but the 
ultimate evolutionary cause that determines the way damage segregates is not known. 
Using deterministic and stochastic models, I fill this knowledge gap. The models 
include concepts such as resource investment tradeoffs, evolutionary optimisation, 
and costs of asymmetry, and implications of the model extend to the transition to 
multicellularity.   
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Chapter 2: An evolutionary model of intra-islet beta-cell dynamics 
2.1       Introduction 
Beta-cell physiology and its central role in glucose homeostasis have been studied at 
the cellular level for several decades. Molecular pathways that enable beta-cells to 
sense blood glucose levels, synthesise insulin, and secrete it have been identified. A 
large network of genes and proteins are involved in these pathways and substantial 
convergence, divergence, synchrony and several other interesting network-related 
phenomena can be recognised in glucose-insulin networks. These properties make the 
system a suitable target for bioinformatic analysis and cell-level systems biology. A 
recently begun initiative in this context is an attempt by the Competence Center for 
Systems Physiology and Metabolic Diseases (http://www.ccspmd.ethz.ch/about/ 
scientific_programs/beta_cell_consortium) to define the surface glycoproteome of 
beta-cells to elucidate sensing, integration and transduction mechanisms that are key 
to beta-cell biology and the development of predictive preclinical models. There are 
several beta cell-level approaches to abnormalities in glucose homeostasis, and 
particularly diabetes (Nolan & Prentki 2008):    
1. Abnormalities in upstream components of beta-cell glucose sensing/signalling 
(from beta-cell membrane to nucleus): G protein-coupled receptor (GPR)-39 is a 
transmembrane receptor that acts as a Zn(++) sensor. Within the endocrine pancreas, 
GPR-39 is mainly located on beta-cells. In a recent experiment, GPR-39(-/-) mice had 
decreased plasma insulin response to oral glucose, expression of Pdx-1 was reduced 
and their purified isolated islets secreted less insulin in response to glucose 
stimulation than islets from wild-type mice. GPR-39 is a potential target for treatment 
of diabetes (Holst et al. 2009). Beta-cells have high capacity for nutrient sensing. The 
drawback is their reduced protection to nutrient toxicity. This potentially explains 
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why in susceptible individuals, chronic fuel oversupply (known as glucolipotoxicity) 
results in beta-cell failure and type 2 diabetes. Both fatty acids and amino acids 
interact with glucose signalling in beta-cells. While glucose entry into most other 
types of cells in the body is reduced (insulin resistance) under fuel overload 
conditions (a beneficial adaptive process to prevent tissue dysfunction from fuel 
overload) (Vannucci et al. 1997; Kraegen et al. 2001; Krebs & Roden 2004; Tremblay 
et al. 2007), beta-cells have to prevent hyperglycaemia and hyperlipidaemia and to 
protect all tissues in the body from fuel surfeit toxicity and potential death. Therefore, 
they do not protect themselves by blocking uptake of excess nutrients. Rather, they 
are there to secrete as much insulin as required. Interestingly, the recent search for 
type 2 diabetes genetic factors has identified more polymorphisms in genes involved 
in beta-cell growth and function than in genes related to insulin action (Frayling 2007; 
Sladek et al. 2007).  
 
The glucose sensing/signalling pathway is evolutionary conserved. For example, 
AMP-activated protein kinase (AMPK) is a widely conserved Ser/Thr-specific protein 
kinase, homologous to Saccharomyces cerevisiae Snf1, and involved in nutrient 
sensing in lower organisms. This enzyme is also involved in glucose homeostasis in 
mammals (Rutter et al. 2003). Given this conservation, significant insight into both 
beta-cell physiology and pathology may be achieved by looking at less complex 
organisms.  
 
2. Abnormalities in downstream components of beta-cell glucose 
sensing/signalling: This involves impairments in insulin synthesis/secretion in 
response to the received information. Enhanced function (insulin synthesis and 
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secretion) is part of the healthy compensatory response of beta-cells to nutrient 
overload. Pancreatic beta-cell failure due to excess nutrients is more likely to occur if 
there is an underlying genetic (Sladek et al. 2007) susceptibility defect. This is evident 
by comparing the diabetes resistant ZF with the diabetes prone Zucker diabetic fatty 
(ZDF) rat (Prentki & Nolan 2006). Both animals are similarly hyperphagic and insulin 
resistant, but the ZDF has a minor defect in its insulin promoter. It is only the ZDF 
rats that develop severe diabetes (Griffen et al. 2001).  
 
3. Abnormalities in beta-cell survival/proliferation: Survival of beta-cells in 
situations of chronic fuel oversupply and insulin resistance undoubtedly depends on a 
healthy compensatory response involving expansion of beta-cell mass, thus 
decreasing the work of each beta-cell (Prentki & Nolan 2006). We will discuss this in 
more detail below.  
 
Similarly, beta-cell level diagnostic and therapeutic approaches to diabetes focus on 
one or more of the mentioned mechanisms. Let us briefly review some of the 
available strategies:  
1. Upstream and downstream components of beta-cell glucose sensing/signalling 
(from beta-cell membrane to nucleus): Insulin secretagogues (e.g. sulfonylurea drugs 
such as glyburide, glimepiride) are a major group of glucose lowering agents known 
for decades. They stimulate insulin secretion by beta-cells through various 
mechanisms. A very recently identified potential insulin secretagogue is GPR40. 
GPR40 is a G protein-coupled receptor regulating free fatty acid-induced insulin 
secretion. Studies in transgenic mice overexpressing the hGPR40 gene under control 
of the mouse insulin II promoter showed that these animals had higher levels of 
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glucose-induced insulin secretion suggesting that pharmacological activation of 
GPR40 may be beneficial for the treatment of type 2 diabetes (Nagasumi et al. 2009). 
 
2. Beta-cell survival/proliferation: Treatment with various growth factors such as 
glucagon-like peptide-1 (GLP-1), betacellulin (BTC), hepatocyte growth factor 
(HGF), and epidermal growth factor (EGF) and forced expression of beta-cell 
transcription factors such as Pdx-1, NeuroD, and MafA resulted in the regeneration of 
beta-cells in vivo. These strategies, however, are not at the time of writing ready for 
clinical application. The cWnt signalling pathway is known to be involved in beta-cell 
growth and function. Recent studies have shown that R-spondin-1 (Rspo1; an 
intestinal growth factor) exerts its effects through activation of the cWnt pathway, and 
may thus be used in future for potential therapeutic purposes (Wong et al. 2010).  
 
These approaches, however, do not encompass the whole spectrum of diagnostic and 
therapeutic methods that are currently available. For example, new biomarkers that 
serve as signatures of the diabetic state and to predict disease are an active field of 
research. They can be targets for small molecule modulators and biologicals. A 
combination of metabolomics and transcriptomics may link known metabolites and 
genes to relevant biochemical pathways. In a recent study (Connor et al. 2010), 
urinary NMR-based metabolomic and liver, adipose, and muscle transcriptomic 
results were used to discriminate between the diabetic db/db and control db/+ mice. A 
total of 24 distinct pathways were identified that were altered in the diabetic model. 
Several of these pathways were involved in lipid metabolism, gluconeogenesis, 
mitochondrial dysfunction and oxidative stress, as well as protein and amino acid 
metabolism. 
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Another approach, which is related to the one we take here, is looking at the total 
beta-cell number/mass in the pancreas both before and during the course of diabetes. 
For at least two reasons, a cell-level approach is not able to grasp the mass 
parameters. First, pancreatic islets are heterogeneous cell populations, meaning that 
beta-cells may differ in functional details. In order to see what happens at the level of 
the islet (or more generally, pancreas), one has to consider the effect of intercellular 
heterogeneity on common physiopathologic properties of cells. The second reason 
concerns the mechanisms that regulate beta-cell mass dynamics. Intracellular events 
are not the sole regulating mechanism. Adjacent beta-cells interact with each other 
and these interactions modify two crucial determinants of beta-cell mass dynamics, 
that is, beta-cell proliferation and survival. Taken together, the cell-level network 
cannot provide a comprehensive and sufficiently predictive understanding of diabetes 
pathophysiology. It needs to be expanded, and the next level to be investigated is the 
islet level.  
 
A model of postnatal pancreatic β-cell growth in humans is now emerging from 
studies in both humans and rodents. Although some events at some stages are difficult 
to confirm in humans, it is thought to happen as follows. Cell differentiation gives rise 
to the initial β cells of an organism during embryogenesis, and β-cell proliferation 
proceeds at a high rate during late embryogenesis (Bernard-Kargar & Ktorza, 2001), 
but begins to decline postnatally, while β-cell apoptosis occurs at very low rates 
(Scaglia et al. 1997). There is a transient burst of β-cell replication just after birth, 
followed by a transitory rise in β-cell neogenesis (Bonner-Weir 2000). In the later 
phase of this burst, there is a modest increase in apoptosis associated with substantial 
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pancreatic remodelling (Scaglia et al. 1997). The early burst in β-cell growth and 
minor apoptosis result in a marked increase in β-cell mass during the early years of 
life. Throughout childhood and adolescence, the rates of β-cell replication, neogenesis 
and apoptosis drop markedly. In adults, β-cell proliferation and apoptosis rates are 
very low so as to compensate for each other (Bonner-Weir 2000; Lingohr et al. 2002) 
and, as β-cell size stays relatively constant, an optimal β-cell mass can be maintained. 
It was suggested in mice that, postnatally, proliferation is the main process 
contributing to β-cell renewal rather than neogenesis (Dor et al. 2004). During later 
adulthood, β-cell mass may decrease as apoptosis slightly outweighs β-cell growth 
(Rhodes 2005).  
 
As mentioned above, until recently, little attention has been paid to beta-cell mass 
regulation at the tissue level, which has somewhat hindered our progress to a full 
understanding of the complex pathophysiology of type 2 diabetes (Bonner-Weir 
2001). Type 2 diabetes is the result of an eventual failure of beta-cells to adapt their 
mass appropriately (in response to the increased insulin demand due to worsening 
insulin resistance), following a chronic successful compensatory phase (Weir & 
Bonner-Weir 2004). Five stages can be identified in the progression of diabetes, each 
of which is characterized by different changes in beta-cell mass, phenotype, and 
function. In stage 1 (compensation), insulin secretion increases to maintain 
normoglycemia in the face of insulin resistance and/or decreasing beta-cell mass. 
Differentiated function is maintained with intact acute glucose-stimulated insulin 
secretion (GSIS). Stage 2 is a stable state of beta-cell adaptation with loss of beta-cell 
mass and disruption of function (diminished GSIS and beta-cell dedifferentiation). In 
this stage, glucose levels start to rise. Stage 3 is early decompensation. In this 
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transient unstable period glucose levels rise relatively rapidly. Stage 4 (full-blown 
diabetes) follows stage 3, and is characterized as stable decompensation with more 
severe beta-cell dedifferentiation. Finally, we have stage 5 (severe decompensation) 
during which profound reduction takes place in beta-cell mass. With treatment, type 2 
diabetic patients may move from later to earlier stages. Stage 5 is the only irrevresible 
stage during the course of diabetes (Weir & Bonner-Weir 2004). A study of non-
diabetic and diabetic patients matched for obesity, revealed that the relative β-cell 
volume and, therefore, the presumptive β-cell mass is decreased in both obese and 
lean humans with type 2 diabetes compared with their non-diabetic age- and weight-
matched counterparts (Butler et al. 2003). Interestingly, humans with impaired fasting 
glucose already have a decreased relative β-cell volume, suggesting that this is an 
early process that is probably a key factor in the development of type 2 diabetes 
(Butler et al. 2003).  
 
MRI technology has been used to image in vivo beta-cell mass in order to track 
disease progression (Medarova & Moore 2009). Endeavors to find a biological 
structure specific for beta-cells led to the discovery of potential candidates that have 
been tested for noninvasive imaging. Among them is the monoclonal antibody IC2. 
The anti-IC2 monoclonal antibody has binding properties exclusively to insulin-
producing beta-cells. IC2 can thus be used as a useful marker for noninvasive 
functional imaging of native beta-cells. Experiments with a radioisotope-chelated IC2 
structure on pancreas showed that the tracer specifically bound to the beta-cell surface 
and could be detected by nuclear imaging (Saudek et al. 2008). Another molecule, 
which is expressed almost exclusively by beta-cells, is the vesicular monoamine 
transporter type 2 (VMAT2). VMAT2 can be noninvasively imaged with positron 
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emission tomography (PET). Although promising, this technique is still in its early 
stages and cannot be used for clinical evaluation of beta-cell mass during the course 
of diabetes (Ichise & Harris 2010). 
 
Beta-cells of fully diabetic patients show a low proliferation rate, a low insulin 
secretion rate, and a high apoptosis rate. The mechanisms of the events eventually 
leading to type 2 diabetes are poorly understood. During the course of type 2 diabetes, 
there is a gradual rise in beta-cell apoptosis rate due to chronic hyperglycaemia 
(Maedler et al. 2001). Specifically, chronic hyperglycaemia triggers insulin receptor 
substrate-2 (IRS-2) proteosomal degradation, leading to reduced beta-cell survival 
(Lingohr et al. 2006).  
 
Proliferation, apoptosis, and function are strongly interrelated phenomena in all cells 
and for understanding the complexity of the relations involved, mathematical 
modelling is of great potential use. Here, I develop a mechanistic mathematical model 
for the process of beta-cell mass regulation by considering the islet, rather than 
individual beta-cells, as the population unit. The model is based on a trade-off 
between proliferation and function (insulin secretion), which gives the model an 
evolutionary shape. The number of beta-cells in the islet and beta-cell mass are used 
interchangeably herein. 
   
2.2      Previous models 
The model presented here is the first one on intra-islet beta-cell dynamics. Finegood 
et al (1995) and Topp et al (2000) have related models on beta-cell dynamics in the 
whole pancreas. Finegood et al (1995) used the idea that any biological mass 
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dynamics, whether in normal or pathological conditions, can be modelled as a 
birth/death process. They model the balance of cell proliferation, cell growth, and cell 
death. For proper parametrization, they first analysed the data available on 
determinants of beta-cell mass dynamics in normal Sprague-Dawley rats. A 
birth/death process was then built based on the data. The model gave authors some 
insight into the contribution of processes such as neogenesis and cell death, which 
could not be measured in the lab at the time. In a later model, Topp et al (2000) 
developed a more sophisticated mathematical model that included insulin and glucose 
dynamics along with beta-cell mass dynamics. The model was composed of three 
ordinary differential equations, each representing one of the three dynamical 
processes mentioned. Glucose and insulin dynamics were fast relative to beta-cell 
mass dynamics. A stability analysis of the model revealed two stable fixed points 
(representing physiological and pathological steady states) for normal parameter 
values. Mild hyperglycaemia pushed the system to the physiological steady state with 
a high beta-cell mass. More severe glycaemia moved the system toward the 
pathological steady state with reduced beta-cell mass.  The authors observed the 
emergence of a bifurcation point (with increasing glycaemia) at which progressive 
defects in glucose and/or insulin dynamics aggrevated the glycaemia faster than the 
adaptation of the beta -cell mass (which could otherwise correct the glycaemia). As 
mentioned, neither of these models considered the effects within the islet, e.g. the 
effects of intercellular contacts between beta-cells on their proliferation, function, and 
durvival. The present model is the first attempt to fill this gap.   
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2.3      The model 
A system of two coupled ordinary differential equations is developed and explored 
using the concepts of dynamical systems. Notations and definitions are provided in 
Table 2.1. Note that since the volume of the islet is assumed to be constant, insulin 
concentration within the islet is the number of insulin moles with the islet.   
 
Table 2.1. Notations and definitions used in the model 
I : insulin concentration within the islet (mole; constant islet volume) 
s : insulin secretion rate per beta-cell (unit: mole × t-1) 
 : beta-cell mass (number) in the islet (dimensionless) 
D : rate of intra-islet insulin loss (unit: t
-1
)  
maxr : beta-cell proliferation rate in the absence of any intercellular contacts (unit: t
-1
)   
min : beta-cell death rate in the absence of any intercellular contacts (unit: t
-1
) 
c : magnitude of the effect of intercellular contacts on beta-cell proliferation (unit: t-1) 
'c : magnitude of the pro-survival effect of insulin (unit: mol × t-1) 
''c : magnitude of the effect of intercellular contacts on beta-cell death rate (unit: t-1) 
 
Insulin dynamics (Eq. 1): Insulin synthesis occurs by beta-cells. The insulin mRNA is 
translated as a single chain precursor called preproinsulin, and removal of its signal 
peptide during insertion into the endoplasmic reticulum generates proinsulin. 
Proinsulin consists of three domains: an amino-terminal B chain, a carboxy-terminal 
A chain and a connecting peptide in the middle known as the C peptide. Within the 
endoplasmic reticulum, proinsulin is exposed to several specific endopeptidases 
which excise the C peptide, thereby generating the mature form of insulin. Insulin and 
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free C peptide are packaged in the Golgi into secretory granules which accumulate in 
the cytoplasm. When the beta cell is appropriately stimulated, insulin is secreted from 
the cell by exocytosis and diffuses into islet capillary blood. A first-order kinetic 
process (including a constant synthesis rate and beta-cell mass) is used to model 
insulin synthesis. There are two mechanisms for insulin loss: biochemical degradation 
and diffusion out of the islet. Once secreted from beta-cells, insulin diffuses through 
the interstitial space and finds its way to the capillaries (Bendayan 1993). Given the 
concentration dependence of typical diffusion processes, a simple first-order kinetic 
process is also used to model insulin loss.    
DIs
dt
dI
     Eq. 1 
 
Beta-cell mass dynamics (Equations 2-5): An islet is a heterogeneous population of 
individuals (Pipeleers 1992). For simplicity, however, I assume intra-islet 
homogeneity. Beta-cell dynamics depends on apoptosis, necrosis, proliferation, and 
neogenesis. These are the only sources of input or output from the total beta-cell pool. 
Apoptosis, or programmed cell death, is a genetically regulated and active mechanism 
by which a cell commits suicide. Necrosis, on the other hand, is unprogrammed and 
occurs due to severe insults. While necrosis leads to uncontrolled release of 
intracellular content into the surrounding microenvironment, thus triggering the 
immune response, apoptosis does not stimulate the immune system. This is owing to 
regulated packaging of the cellular contents in what we know as apoptotic bodies. 
Apoptotic bodies are inert and will be safely absorbed by neighboring cells when 
released from the dying cell.  
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Neogenesis refers to proliferation and then differentiation of non-beta-cells into beta-
cells. New beta-cells could potentially originate from (i) ductal cells, (ii) already 
differentiated pancreatic cell (i.e., exocrine, acinar or ductal) or extra-pancreatic cells, 
and (iii) an islet precursor cell. Neogenesis from duct epithelium is the most currently 
described and the best documented process by which progenitor cells can differentiate 
into endocrine cells. During fetal life, and in the neonatal period, intense beta-cell 
differentiation is the major contributor to beta-cell mass expansion. Two mechanisms 
are proposed. The first one involves the emergence of cells budding from the duct 
epithelium, and expressing islet hormones, especially insulin. According to a second 
mechanism, that has been described only during the fetal life, the source of beta-cells 
comes from a pool of proliferating cells expressing cytokeratin (CK) and located near 
the ductal tree (Paris 2004).  
Necrosis was ignored in the model due to scarcity of data as was neogenesis due to 
my particular interest in postnatal/adult life when proliferation is the main source for 
new beta-cells (Dor et al. 2004). A simple birth-death process was used to model beta-
cell mass dynamics within the islet; beta-cells proliferate and die at certain rates 
( r and  , respectively).  
)( 

 rr
dt
d
  Eq. 2 
 
Intercellular contacts between beta-cells are known to inhibit beta-cell proliferation 
and decrease their survival. E-cadherin is known to mediate homotypic
 
cell adhesion 
between beta-cells and has also been implicated in
 
a number of cellular processes, 
including proliferation, apoptosis,
 
and differentiation. In an interesting study on the 
growth of
 
insulin-secreting MIN6 cells configured as three-dimensional
 
islet-like 
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clusters (pseudoislets), pseudoislet formation was associated with an increased 
expression
 
of cyclin-dependent kinase inhibitors and a concomitant downregulation
 
of 
Ki67, suggesting an overall reduction in cellular proliferation. Apoptosis was 
upregulated in islet-like structures (Luther et al. 2005). Insulin, on the other hand, is a 
growth factor that promotes beta-cell survival (Aikin et al. 2006; Navarro-Tableros et 
al. 2004). This is achieved by inhibiting apoptosis via the autocrine activation of the 
Akt signalling pathway (Aikin et al. 2006; Johnson et al. 2006). We can formulate 
these observations into the following equations:  
 
crr  max    Eq. 3 


 ''
'
min c
I
c
  Eq. 4 
where maxr is beta-cell proliferation rate in the absence of any intercellular contacts, 
and c models the magnitude of the effect of intercellular contacts on beta-cell 
proliferation rate. min is beta-cell death rate in the absence of any intercellular 
contacts, 'c models the pro-survival effect of insulin (insulin availability per beta-
cell), and ''c shows the magnitude of the effect of intercellular contacts on beta-cell 
death rate.  
 
After substitutions, equations 2-5 can be summarized as 
I
c
ccr
c
I
c
cr
dt
d
2
2
minmax
minmax
'
)''()(
)]''
'
([








  Eq. 5 
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2.4       Results 
Equations 1 and 5 describe a two-dimensional nonlinear dynamical system. One can 
find the fixed points of the system by making the two equations zero and solving for 
  and I . Doing this yields 













)''(
'
''
'
minmax*
minmax
*
ccD
Dcssr
I
cc
s
Dc
r



  Eq. 6 
 
The local Jacobean of the system can be found at the fixed point. The eigenvalues of 
the Jacobian determine local stability of the fixed point. The Jacobian at the fixed 
point is 






2
*
***
)('
),(
I
c
D
IJ    






*
*
*
minmax
'2
)''(2
I
c
ccr
s


  Eq. 7  
  
Both eigenvalues can be shown to be real because  
0)('4]
'2
)''(2[ 2
*
*
2
*
*
*
minmax 
I
scD
I
c
ccr

  
The sum and the product of the eigenvalues are 
)
'
(
2
minmax
maxmin
s
Dc
rDP
Dr
S





 
 
Taken together, the following two cases can be observed: 
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(i) 
s
Dc
r
'
minmax    (Figure 2.1 and 2.2): The fixed point is a local saddle and 
the values of both   and I at the fixed point are negative. This means, in particular, 
that   decreases to zero. From a biological point of view, the outcome of this 
situation is disappearance of islets and full-blown diabetes (unless there is sufficient 
inter-islet heterogeneity and compensation by healthier islets).   
 
 
Figure 2.1: Steady state analysis when minmax r  (case (i)). Both beta-cell mass 
and insulin levels approach zero with time. 
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Figure 2.2: Steady state analysis when 
s
Dc
r
'
minmaxmin    (case (i)). Both 
beta-cell mass and insulin levels approach zero with time. 
 
(ii) 
s
Dc
r
'
minmax   (Figure 2.3 and 2.4): The fixed point is locally stable and the 
values of both   and I at the fixed point are positive. This case represents a 
biologically more interesting situation. The islet contains a stable number of beta-cells 
and a stable amount of insulin.   
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Figure 2.3: Steady state analysis when 
s
Dc
r
'
minmax   (case (ii)). There is a 
biologically relevant steady state for both beta-cells mass and insulin levels. 
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Figure 2.4: Steady state analysis for different values of maxr and s . When the 
values of maxr (proliferation rate in the absence of intercellular contacts) and s (insulin 
secretion rate per beta-cell) are above the shown curve, there is a biologically relevant 
steady state for both beta-cell mass and insulin levels.   
 
The next important question concerns the determinants of the stable beta-cell mass in 
case (ii). maxr is inversely related to s . Let us represent this relationship by  
)(max sfr   
in which f decreases with s . This is due to the regulatory role of c-Myc, which 
promotes proliferation at the cost of insulin secretion (Demeterco et al. 2002). There 
are several lines of evidence supporting the existence of this trade-off. Mature beta-
cells have low c-Myc expression (Jonas et al. 1999; Katić et al. 1999), which is 
consistent with a low proliferation rate (Bonner-Weir 2000). The state of 
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differentiation of beta-cells is inversely correlated with their proliferation rate 
(Philippe et al. 1987). Highly proliferative beta-cells of foetal islets do not show 
glucose-induced insulin response (an index of maturity/differentiation) (Bonner-Weir 
2001). Glycaemia, the most potent stimulator of beta-cell proliferation, acts by 
inducing c-Myc overexpression which in turn stimulates beta-cell proliferation and 
impairs insulin gene expression (Jonas et al. 2001; Laybutt et al. 2002). The latter 
occurs by binding of c-Myc to the E-box element in the insulin promoter and 
inhibiting NeuroD-mediated transcriptional activation (Kaneto et al. 2002). Finally, 
the pancreatic and duodenum homeobox factor-1 (Pdx1), an essential factor for 
insulin gene expression, suppresses c-Myc and results in a low proliferation rate 
(Chen et al. 2007).  
 
Since maxr is constrained by values of s , the biologically relevant outcome of evolution 
in case (ii) may or may not occur, depending on the shape and parameters of the 
function f . Figure 2.5 shows a few of the several possibilities.  
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Figure 2.5: Steady state analysis for different patterns of relationship between 
maxr and s . For a given relationship between maxr (proliferation rate in the absence of 
intercellular contacts) and s  (insulin secretion rate per beta-cell), one can see whether 
the outcome of evolution is a biologically relevant stable steady state. Shown are 
curve 1, part of which lies above the arrowed curve, and curve 2, all of which lie 
below the arrowed curve. Only in the former can the outcome of evolution be a 
biologically relevant stable steady state.   
 
The first derivative of   in terms of s determines the steady state value of   for 
different values of s . We have 
''
'
2*
cc
s
Dc
ds
df
ds
d




 
where 
ds
df
is negative and is calculated at s . Depending on the behaviour of 
ds
df
, 
ds
d *
can have different behaviours (Figure 2.6), which one classify in the following 
three categories: 
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Figure 2.6: Steady state value of beta-cell mass versus s . When 
ds
d *
is positive for 
small values of s (insulin secretion rate per beta-cell) and negative for larger values of 
s , there is an intermediate value of s  for which the steady state beta-cell mass in 
maximal.   
 
(a) 
ds
d *
is always positive (Figure 2.6): In this case, more insulin secretion (per 
beta-cell) rewards larger beta-cell mass. Although more insulin secretion is associated 
with slower proliferation, the pro-survival effect of insulin can compensate and result 
in a larger beta-cell mass.  
(b) 
ds
d *
is always negative (Figure 2.6): In this case, more insulin secretion (per 
beta-cell) results in smaller beta-cell mass. Beta-cell proliferation rate is more 
important than insulin secretion for beta-cell mass in this situation.   
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(c) 
ds
d *
is initially (for small values of s ) positive and then negative (Figure 2.6): 
In this interesting case, maximal beta-cell mass is achieved with intermediate rates of 
insulin secretion per beta-cell (arrow in Figure 2.6). Too high rates of insulin 
secretion seriously compromise proliferation and too high rates of proliferation 
seriously compromise insulin secretion.   
 
2.5       Discussion 
The present model is the first mechanistic model of intra-islet beta-cell dynamics. The 
next step towards a better understanding of beta-cell dynamics is to include the 
heterogeneity that exists both within and among islets. There are intercellular 
differences in the secretory activity of glucose-exposed beta cells, both in terms of 
glucose sensitivity and of amplitude. Heterogeneity also exists in cellular metabolic 
and biosynthetic functions (Karaca et al. 2009; Van Schravendijk et al. 1992). Two 
subpopulations of beta-cells can be identified in the pancreas. Highly responsive beta-
cells express functional beta-cell markers and are highly responsive to various insulin 
secretagogues, whereas weakly responsive or nonresponsive beta-cells represent the 
main population in diabetic pancreas. An increase in highly responsive beta-cells has 
been shown to be associated with gain of function that follows sustained glucose 
overload (Karaca 2009). From a physiological point of view, it is important to note 
that functional consequences of heterogeneity need to be overcome by certain 
mechanisms in order for pulsatile and coordinated insulin secretion from pancreas to 
take place. Through computational modelling, it was proposed recently that 
cholinergic neural ganglia can serve as an islet-synchronizing agent. Specifically, 
periodic pulses of acetylcholine released from cholinergic neurons are able to 
coordinate the activity of a population of simulated islets, even if only a fraction of 
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these are innervated (Fendler et al. 2009). There is a rich innervation of the pancreas 
by preganglionic vagal neurons (Ahren et al. 1986; Berthoud & Powley 1990; 
Brunicardi et al. 1995; Kirchgessner & Gershon. 1990). These autonomic nerves 
synapse onto intrapancreatic ganglia. These ganglia are often found in the proximity 
of islets and provide innervation (Coupland et al. 1958; Morgan & Lobl, 1968; 
Persson-Sjogren et al. 2001).  
 
Case (i), studied above, corresponds to full-blown diabetes in which islets become 
depleted of beta-cells and consequently insulin levels diminish. Based on my 
calculations, one straightforward condition for this to occur is a sufficient elevation in 
baseline apoptosis rate of beta-cells. Indeed, stress-induced apoptotic beta-cell death 
is a hallmark of type 2 diabetes (Szabadkai & Duchen 2009). Alternatively, an 
impaired balance between proliferation and insulin secretion is predicted by the model 
to be able to result in case (i). In support of this prediction, the primary progenitor of 
type 2 diabetes is now presumed to be progressive beta-cell dysfunction, which 
appears early in the clinical course (Campbell 2009). The combination of excessive 
levels of fatty acids and glucose leads to decreased insulin secretion, impaired insulin 
gene expression, and beta-cell death by apoptosis, which probably have distinct 
underlying mechanisms (Poitout et al. 2009).  
 
Case (ii) represents a milder form of the conditions that exist in case (i). In this case, 
the islet approaches a steady state regarding beta-cell mass and insulin. As long as 
new interfering conditions such as medications and new diseases are not added to the 
scenario, the model predicts that the steady state is stable. This situation corresponds 
to stable diabetes. The patient may suffer from hyperglycaemia and its complications 
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(which might make the steady state less stable or unstable and shift it to a new point), 
but the situation is at least transiently stable. Under what conditions can case (ii) 
progress and result and convert to case (i)? A rise in baseline beta-cell apoptosis rate 
( min ) may facilitate this transition. A sufficiently severe immune assault, resulting 
for example from an acute inflammation, can increase beta-cell apoptosis rate and 
mediate the transition from stable diabetes to case (ii). The same process is active in 
type 1 diabetes (Rabinovitch 1998; Rabinovitch & Suarez-Pinzon 2007; Mandrup-
Poulsen 1996). Morphological studies have uncovered an intra-islet inflammatory 
process in type 2 diabetes, characterized by the presence of cytokines (e.g. interleukin 
1-beta), immune cells, and beta-cell apoptosis, among others. Importantly, increased 
numbers of macrophages are detectable very early in high fat-fed mice islets, before 
the onset of diabetes. These immune cells are most likely attracted by islet-derived 
chemokines, produced in response to metabolic stress, and under the control of 
interleukin-1 beta. Modulation of intra-islet inflammatory mediators, in particular IL-
1 beta, has been suggested as a strategy to prevent insulitis in type 2 diabetes (Böni-
Schnetzler 2008). Insulitis has been suggested to contribute to the decrease in beta-
cell mass in type 2 diabetes (Donath et al. 2009). The present model predicts that if 
insulitis is added to a stable diabetes scenario, a bifurcation may take place and 
convert the case to unstable and progressive hyperglycaemia, eventually resulting in 
full-blown diabetes.  
 
How can the model presented here and its results be applied in clinical setting? As the 
first attempt to model intra-islet beta-cell dynamics, there is still much to be included 
and explored in the model. The model can be more sophisticated (and possibly with 
more explanatory power) if it includes molecular pathways that mediate the three 
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main functions related to beta-cells: proliferation, apoptosis, and insulin secretion. 
There may well be additional trade-offs between the three (I only considered the 
trade-off between proliferation and insulin secretion) with significant effects on beta-
cell dynamics. In its current form, and to my best knowledge, the model takes 
advantage of the most compelling evidence to explain the phenomenon of our interest. 
The generic structure of the model makes it flexible enough to become more 
sophisticated as new data emerge.      
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Chapter 3: Metabolic evolution suggests an explanation for the 
weakness of antioxidant defences in beta-cells 
3.1       Introduction 
3.1.1    Beta-cells and glucose homeostasis 
Beta-cells are major constituents of the endocrine pancreas and are localized within 
specialized structures (the islets of Langerhans) throughout the pancreas (Figure 3.1). 
Beta-cells are believed to have first evolved as scattered insulin-producing cells in the 
intestinal tissue of primitive proto-chordates (> 500 million years ago). During the 
evolution of the hagfish and lampreys (~ 500 million years ago), our most primitive 
vertebrate species of today, they formed the endocrine pancreas within the abdominal 
cavity (Madsen 2007). Embryonic development of the endocrine pancreas involves 
sequential, cell-specific expression of transcriptional factors that determine the fate of 
individual cell types within the foetal pancreas (Habener et al. 2005). For example, 
expression of pancreatic duodenal homeobox-1 (PDX-1) and MafA (activators of 
insulin gene transcription) during gestation (8-21 weeks in humans) is associated with 
beta-cell differentiation and insulin production (Kaneto et al. 2007; Lyttle et al. 2008). 
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Figure 3.1: Schematic histology of the pancreas. Pancreatic islets are collections of 
endocrine cells (including beta-cells) scattered in between the exocrine acini.   
 
Beta-cells play a central role in whole-body glucose homeostasis. The enormously 
complicated organism-level process that results in glucose homeostasis can be 
simplified, for the sake of the present discussion, as a feedback loop between plasma 
glucose and insulin (Figure 3.2). A rise in blood glucose, e.g. after a meal, is 
converted to a stimulatory signal inside beta-cells, leading to increased insulin 
synthesis and secretion. Following exocytosis and entry into the bloodstream, insulin 
promotes, via insulin receptors on the cell membrane, glucose disposal in various 
tissues such as the liver and skeletal muscles (for exceptions see below). 
Consequently, plasma glucose is robustly maintained within a narrow range (~70-100 
mg/dl in humans), thus providing exclusively glucose-dependent organs such as the 
brain with a reliable energy supply. Uncorrected deviations from homeostasis can 
have detrimental outcomes, most notably seizure (with hypoglycaemia) and diabetes 
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(with hyperglycaemia). Maintenance of glucose homeostasis is contingent upon 
proper beta-cell function, well-regulated beta-cell mass (i.e. number), and appropriate 
peripheral response to insulin.  
 
Figure 3.2: Main elements of the glucose homeostatic system. Beta-cells sense the 
blood glucose and secrete insulin which in turn reduces blood glucose and maintains 
homeostasis. 
 
Figure 3.3 provides a simplified overview of glucose-induced insulin secretion in 
beta-cells and insulin-induced glucose disposal in other cell types in the body. With a 
few exceptions including beta-cells, the brain and the placenta, glucose disposal 
depends on insulin availability in the vicinity of the cell (Watve & Yajnik 2007). 
Binding of insulin to insulin receptors on the surface of the cell activates an 
intracellular signaling pathway among the effects of which is the transport of glucose 
receptors to the cell membrane allowing for glucose entry (Fröjdö et al. 2009). 
Impairment in this signaling pathway is known as insulin resistance and is a central 
feature of an increasingly common constellation of pathologies collectively known as 
metabolic syndrome. In beta-cells, the ATP-controlled potassium channels on the cell 
surface close following the rise in cellular ATP concentrations that are produced by 
glucose metabolism. The consequent depolarization of the cell membrane promotes 
calcium entry to the cell via calcium channels. Increased amounts of calcium in the 
cell cause release of previously synthesized insulin. Glucose also regulates insulin 
synthesis at both transcriptional and post-transcriptional levels (Andrali et al. 2008).   
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Figure 3.3: Glucose-induced insulin secretion in beta-cells and peripheral 
insulin-induced glucose disposal. The ATP generated following glucose metabolism 
results in calcium entry into the beta-cell and insulin secretion. In peripheral tissues, 
one effect of insulin signaling is the translocation of glucose transporters to the cell 
membrane and glucose disposal.  
 
3.1.2    Reactive oxygen species: effects on beta-cells 
Glucose metabolism in the cell leads to the generation of reactive oxygen species 
(ROS) which negatively affect the insulin synthesis/secretion machinery via several 
mechanisms (Wiederkehr & Wollheim 2006). Insulin gene transcription is regulated 
by a number of transcription factors, most notably PDX-1 and RIPE3b1a/MafA. ROS 
negatively affect both of these transcription factors (Harmon et al. 2005; Kaneto et al. 
2005; Poitout et al. 1996; Read et al. 1997; Robertson et al. 2003). Fusion of insulin 
vesicles with the cell membrane depends on intracellular concentrations of calcium, 
which rise as a result of calcium flow into the cell through calcium channels. Calcium 
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channels open following the closure of ATP-dependent potassium channels and 
membrane depolarization. Any event that reduces cellular ATP levels may result in 
the closure of potassium channels. In particular, superoxide ions activate uncoupling 
protein-2 (UCP-2)-mediated proton leak and lower ATP levels, impairing glucose-
mediated insulin secretion (Krauss et al. 2003).  
 
The effects of transiently elevated glucose concentrations on ROS generation are 
opposite to those of prolonged glycaemia. Glucose acutely suppressed ROS formation 
in rat beta-cells by increasing cellular NADH levels (Martens et al. 2005). However, 
this effect was limited. ROS production quickly surpassed its rate of elimination, 
leading to intracellular ROS accumulation (Gurgul et al. 2004; Pi et al. 2007; Tiedge 
et al. 1997). That beta-cells show different behaviors under conditions of acute versus 
prolonged stress is probably a more universal finding applicable to other systems, and 
can be evolutionarily explained by considering what is “good” for the organism. 
Homeostatic systems evolve to allow the organism to resist transient environmental 
noise; the organism should not change its strategies when the same environment is 
likely to be encountered shortly after a transient perturbation. However, when the 
environment seems to be deviating, for long, from its current status, adherence to a 
non-flexible homeostatic system can be detrimental. Physiological systems are neither 
too fragile nor too strictly homeostatic. My hypothesis (see below) only concerns 
prolonged stress conditions.  
 
3.1.3    Antioxidant defences in beta-cells versus other cell types 
Given their slow turnover (Teta et al. 2005) and their central role in glucose 
homeostasis, beta-cells are expected to possess an efficient defence system that 
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protects them against various insults, including ROS. The three main antioxidant 
enzymes are superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase 
(GPx) (Chance et al. 1979). SOD converts superoxide (O2
-
) molecules to less toxic 
molecules of H2O2, which may then be converted to oxygen and water by the 
enzymes catalase (CAT) and glutathione peroxidase (GPx) (Pi et al. 2007; Rhee et al. 
2005). In human beta-cells, the expression pattern of the three main antioxidants is 
SOD>CAT>GPx (Tonooka et al. 2007). The same situation holds true in human liver 
cells (Asikainen et al. 1998), but antioxidants in human lung cells seem to have a 
different expression pattern: CAT>GPx>SOD (Asikainen et al. 1998). Antioxidant 
expression is cell-specific and different cell types may differ in their antioxidant 
responsiveness to intracellular redox changes (Asikainen et al. 1998; Jornot & Junod 
1993).  
 
Comparative studies have demonstrated that antioxidant defences are remarkably 
weaker and less responsive to oxidative challenge in beta-cells than in other tissues 
such as liver, kidney, brain, lung, skeletal muscle, heart muscle, adrenal gland and 
pituitary gland (Grankvist et al. 1981; Lenzen et al. 1996; Malaisse et al. 1982; Tiedge 
et al. 1997; Zhang et al. 1995). For example, GPx is expressed at very low levels and 
has almost undetectable activity in both human (Robertson & Harmon 2007; Tonooka 
et al. 2007) and rodent beta-cells (Grankvist et al. 1981; Tiedge et al. 1997). Catalase 
activity in human beta-cells is at the same level as, if not even lower than, in rat beta-
cells (Sigfrid et al. 2003). Catalase gene expression is nearly undetectable in mouse 
beta-cells (Lenzen et al. 1996) and in rats is approximately 5% of the liver (Tiedge et 
al. 1997).   
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The weakness of antioxidant defences in beta-cells is clinically relevant. Several lines 
of evidence point to oxidative stress as a causative factor in the pathogenesis of type 2 
diabetes. Compared to healthy controls, islets of type 2 diabetic patients contain 
significantly higher levels of oxidative stress markers (Chang-Chen et al. 2008), 
possibly because beta-cell function and turnover are highly susceptible to the adverse 
effects of prolonged glycaemia. The insufficiently countered oxygen radicals 
generated over time as a result of chronic exposure to glycaemia are believed to 
damage beta-cell function and turnover mechanisms (Tanaka et al. 2002). Taken 
together, the lack of a strong (antioxidant) defence system has been an increasingly 
likely suspect for beta-cell sensitivity to ROS (Kajimoto & Kaneto 2004; Lenzen 
2008; Robertson et al. 2003).  
 
3.1.4    Beta-cell antioxidant defences: gender differences  
Beta-cell antioxidants have lower levels of activity in female mice than in males 
(Cornelius et al. 1993). Humans are no different. Tonooka et al (2007) performed one 
of the few studies on human beta-cell antioxidants. They observed that GPx protein 
expression was remarkably low and GPx activity was almost undetectable in the 
islets. Furthermore, they demonstrated under varying glucose concentrations that GPx 
protein expression was significantly lower in islets from females (Tonooka et al. 
2007). There are no studies, to our knowledge, that have looked at gender-specific 
patterns in beta-cell antioxidant expression in species other than mice and humans.  
 
Beta-cells seem to be rather unique among other cells in this regard. Indeed, females 
are generally better protected against oxidative stress (Proteggente et al. 2002). For 
example, mitochondria from female rats had higher antioxidant gene expression than 
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those from males in one study. Ovariectomy removed this difference, which re-
appeared following estrogen replacement therapy (Borrás et al. 2003). Among tissues 
where ovariectomy causes a significant reduction in antioxidant expression and 
activity are bones (Muthusami et al. 2005) and the liver (Oztekin et al. 2007).   
The proximate mechanisms underlying this gender difference are not clear. Estrogen 
has a phenol ring containing a hydroxyl group which may be donated. This structure 
offers estrogen a possible chain-breaking antioxidant mechanism of action, like that of 
vitamin E (Subbiah et al. 1993; Sugioka et al. 1987). However, physiological 
concentrations of estrogen are not high enough to exert significant effects on the 
cellular redox state. Indirect effects such as membrane stabilization are a more likely 
mechanism for the antioxidant properties of estrogen at physiological concentrations 
(Paroo et al. 2002). Beta-cells do not seem to follow the same response pattern to sex 
hormones as other cell types. It is androgens, rather than estrogen, that provide some 
protection for beta-cells, by reducing mega-islet formation (Rosmalen et al. 2001) and 
apoptosis (Morimoto et al. 2005). 
  
3.1.5    Observations to be explained, questions to be answered 
Taken together, the evidence prompts the following questions: Is there some 
advantage in possessing a reduced antioxidant status that outweighs the high price that 
is paid in terms of cellular vulnerability to ROS? Does the difference between the 
sexes have its origin in some sex-specific evolutionary factor? I examine the 
possibility that an answer to the first question might lie in a regulatory role for ROS in 
the essential function of beta-cells, i.e. insulin secretion. I also consider the idea that 
the weaker antioxidant system in females might be related to pregnancy. First I link 
the effects of ROS on beta-cells to organism-level physiological changes that occur 
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during the stress response. Finally, a resource allocation argument in the context of 
pregnancy and reproductive success of the organism will be used to complete the 
hypothesis.   
 
3.2      The hypothesis 
3.2.1   The stress response and pregnancy 
With a few exceptions, namely the brain and placenta, glucose disposal in cells 
depends on insulin availability in the micro-environment (Peters et al. 2002; Watve & 
Yajnik 2007). Therefore, decreased insulin sensitivity does not affect insulin-
independent cell types which become preferential destinations for the net extra 
glucose available in the blood in insulin resistant states. Corticosteroids (released 
during the stress response) and tumor necrosis factor- α (released during pregnancy) 
cause impairments in the insulin signaling pathway that leads to insulin-induced 
glucose disposal, thus making stress conditions and pregnancy two important insulin 
resistant states (Kirwan et al. 2004; Qi & Rodrigues 2007). Both acute and chronic 
stress activate the hypothalamic-pituitary-adrenal (HPA) axis and result in 
glucocorticoid release into the bloodstream. In spite of differences in upstream events, 
the response elicited by both types of stress is qualitatively similar (Chowdrey et al. 
1995; Harbuz et al. 1992; Lightman 2008).  
 
The average plasma glucose levels in pregnancy are lower than in non-pregnant 
women. This is mostly due to increased plasma volume in the first trimester and 
increased foeto-placental glucose utilisation in late gestation. Also, the glucose set-
point is lowered by prolactin, which promotes glucose oxidation in beta-cells by up-
regulating the expression of glucose transporters on the cell surface and increasing the 
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activity of glucokinase (glucose sensor) (Weinhaus et al. 1996). This resetting takes 
place in the first trimester (Butte 2000; Mills et al. 1998) and ensures that the mother 
will be able to avoid glycaemia as insulin sensitivity declines during the course of 
pregnancy (see below). 
 
During the third trimester the average diurnal plasma glucose shows a gradual rise, 
well within the normal range owing to the above protective mechanisms (Parretti et al. 
2001) (Figure 3.4). Decreased insulin sensitivity (Yamashita et al. 2000) and 
increased fasting hepatic glucose production (Catalano et al. 1992), resulting in 
increased postprandial glucose, are responsible for this change. Insulin resistance of 
pregnancy results from impaired insulin signalling due to well-known post-receptor 
defects (Catalano et al. 2002; Kirwan et al. 2004; Saad et al. 1997; Shao et al. 2000), 
mainly in skeletal muscles and adipose tissues (González et al. 2002). In particular, 
insulin sensitivity is blunted by up to 45–70% during the third trimester (Butte 2000; 
Catalano et al. 1991; Catalano et al. 1993), which is associated with a compensatory 
rise of fasting plasma insulin (Assel et al. 1993; Catalano et al. 1993). Tumour 
necrosis factor-α plays the role of classical stress hormones (see above) in mediating 
insulin resistance in pregnancy (Kirwan et al. 2004). 
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Figure 3.4: Mean diurnal glucose concentrations in the third trimester. Data were 
collected from 51 women with normal glucose tolerance who delivered term live-born 
infants without evidence of congenital malformations (Adapted from (Parretti et al. 
2001)) 
 
The process of beta-cell mass regulation undergoes some alteration during pregnancy 
resulting from the interplay of several factors, most importantly glucocorticoids and 
lactogens (Arumugam et al. 2008). Glucocorticoids are an essential component of 
normal pregnancy with pluripotent effects on decidualisation, implantation, and 
placental development (Arcuri et al. 1996; Malassiné & Cronier 2002). They have, 
however, some undesired effects on both the mother and foetus if not counteracted. 
The placenta protects the foetus from high levels of maternal cortisol through its 
enzyme 11β-hydroxysteroid dehydrogenase type 2, which converts cortisol to inactive 
cortisone (Shams et al. 1998). On the maternal side, cortisol concentrations double in 
late gestation leading to increased beta-cell apoptosis and decreased proliferation 
(Freemark 2006; Ranta et al. 2006; Weinhaus et al. 2000). The effects of lactogens on 
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beta-cells are exactly opposite to those of cortisol (Arumugam et al. 2008; Fujinaka et 
al. 2007), and may therefore function to counteract the detrimental effects of 
corticosteroids on the glucose homeostatic system. The net result may be enhanced 
beta-cell mass during gestation. 
 
Table 3.1 summarizes the changes that occur during pregnancy in glucose 
homeostasis and beta-cell physiology. For the purpose of my hypothesis, it is to be 
noted that plasma glucose rises within the normal range during pregnancy, 
particularly in the third trimester (Parretti et al. 2001). Beta-cells respond by secreting 
more insulin to compensate.  
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   Table 3.1: Summary of the changes that occur in glucose homeostasis in pregnancy 
Beta-cell mass 
regulation 
-Late gestational increase in glucocorticoids 
increase beta-cell apoptosis and decrease beta-
cell proliferation. 
-Lactogens decrease beta-cell apoptosis and 
increase beta-cell proliferation.  
-Net result: increased beta-cell mass during 
gestation 
(Freemark 2006; Ranta et al. 
2006; Weinhaus et al. 2000)  
 
(Arumugam et al. 2008; 
Fujinaka et al. 2007) 
(Sorenson & Brelje 1997) 
Glucocorticoid 
metabolism 
 -Glucocorticoids are important for 
decidualisation, implantation, and placental 
development but have undesired effects if not 
counteracted.   
 -The placental 11ß-hydroxysteroid
 
dehydrogenase type 2 converts cortisol to 
inactive cortisone and protects the foetus.  
 -Attenuated HPA axis stress responsiveness is 
another protective mechanism.  
(Arcuri et al. 1996; 
Malassiné & Cronier 2002) 
 
 
(Shams et al. 1998) 
 
 
(Weinstock 1997) 
Insulin 
sensitivity 
 -Post-receptor defects in insulin signaling 
mainly in skeletal muscles and adipose tissues 
  
 
-Blunting of insulin sensitivity more than 50% in 
the 3
rd
 trimester 
 
 -TNF-α plays the role of stress hormones  
(Catalano et al. 2002; 
González et al. 2002; 
Kirwan et al. 2004; Saad et 
al. 1997; Shao et al. 2000) 
(Butte 2000; Catalano et al. 
1991; Catalano et al. 1993; 
Yamashita et al. 2000) 
(Kirwan et al. 2004)  
Glucose
a -Prolactin lowers the glucose set-point by up-
regulating the expression of glucose 
transporters and glucokinase (glucose sensor) 
activity in beta-cells (1
st
 trimester)
b 
-Increased fasting hepatic glucose production, 
increased plasma volume in the 1
st
 trimester and 
increased foetoplacental glucose utilization in 
late gestation 
-Net result: lower plasma glucose levels than in 
non-pregnant women, with a gradual rise in the 
3
rd
 trimester 
(Butte 2000; Mills et al. 
1998; Weinhaus et al. 1996) 
 
 
(Catalano et al. 1992)  
 
 
 
(Parretti et al. 2001) 
Insulin -Increased metabolic clearance of insulin, due 
partly to placental insulinase
c
  
- Compensatory rise of fasting plasma insulin 
(Catalano et al. 1998; 
Posner 1973) 
(Assel et al. 1993; Catalano 
et al. 1993) 
a
The maternal plasma glucose level is strongly correlated to utero-placental glucose 
consumption, glucose transfer to the foetus and foetal plasma glucose (Hay, 1995; Hay and 
Meznarich, 1989).   
b
This mechanism protects the mother against glycaemia as insulin sensitivity declines in the 
course of pregnancy.  
c
This mechanism may aid ROS in reducing plasma insulin (see text). 
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3.2.2    Hypothesis: ROS in beta-cells have an adaptive function in stress 
conditions including pregnancy 
Natural selection strongly favours strategies that maximize the production of offspring 
and is therefore expected to have acted, in female mammals, to tune physiological 
systems to optimize the chances of a successful pregnancy. Since the placenta is an 
insulin-independent tissue, maternal insulin resistance can help divert more glucose to 
the foetus (Watve & Yajnik 2007). The gradual increase in maternal average plasma 
glucose following the development of insulin resistance is also explained by the 
necessity to meet the increasing nutritional requirements of the growing foetus. In 
support of this, note that utero-placental glucose consumption, glucose transfer to the 
foetus and foetal plasma glucose are all directly and strongly related to maternal 
plasma glucose (Hay 1995; Hay & Meznarich 1989). 
 
However, if the above argument is correct, then why is the compensatory 
hyperinsulinaemia unable to return glucose back to the set-point, thereby maintaining 
homeostasis at a relatively constant glucose level? There are two possibilities. Either 
at some point, beta-cells are simply unable to increase the rate of insulin secretion 
further, perhaps because they are exhausted or because insulin resistance progresses 
faster than they can compensate for by augmenting insulin secretion. Or, there is some 
reason, possibly adaptive, why beta-cells do not increase insulin secretion rate further. 
 
There are powerful arguments against the first of these possibilities. Firstly, insulin 
resistance develops and progresses very slowly. Secondly, reduced plasma glucose 
lessens the metabolic load that would otherwise be imposed on beta-cells in insulin 
resistant states. Finally, no signs of beta-cell exhaustion or failure have been described 
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in a normal pregnancy. The second possibility requires beta-cells to be prevented 
somehow from secreting insulin at the level required to return glucose back to the set-
point. I suggest that ROS are suitable candidates for playing this inhibitory role and 
that antioxidants are therefore expressed at a sufficiently low level to allow for ROS 
to perform their important regulatory function during pregnancy. The function of ROS 
in reducing the plasma insulin is aided by an increased metabolic clearance of insulin 
with advancing gestation. The precise mechanisms of this alteration in insulin 
clearance are unclear, but seem to involve the placental insulinase (Catalano et al. 
1998; Posner 1973). A simple mathematical model clarifies the hypothesis (see 
Appendix). 
 
3.2.3    Summary of the hypothesis 
From an evolutionary perspective, pancreatic beta-cells and their weak protection 
against oxidative stress represent an intriguing puzzle. The hypothesis states that beta-
cells evolved their weak antioxidant protection to allow for reactive oxygen species 
(ROS) to exert a regulatory function directly linked with reproductive fitness of the 
organism (Rashidi et al. 2009a; Rashidi et al. 2009b). The hypothesis throws new 
light on the trade-offs that are involved in the evolutionary optimization of 
metabolism. The use of this kind of evolutionary physiology approach has already 
provided insights into the underpinning of important features of human ageing and 
age-related diseases. For example, there are interesting inferences to be made about 
the phenomenon of the human menopause and whether or not it is functionally 
distinct from the generalized reproductive senescence that occurs in other species 
(Rashidi & Shanley 2009). If my hypothesis concerning beta-cells is correct, it may 
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yield new ways to think about the pathogenesis of a common age-related disorder, 
type 2 diabetes. Now, I discuss further the implications of the hypothesis. 
 
3.3      Looking into the past: co-evolution or coincidence? 
Beta-cells first evolved as scattered insulin-producing cells in the intestinal tissue of 
primitive proto-chordates such as amphioxus (>500 million years ago) to sense gut 
glucose. During the evolution of the hagfish and lampreys ( 500 million years ago), 
our most primitive vertebrate species of today, they formed the endocrine pancreas to 
sense blood glucose. This was concurrent with the evolution of the most primitive (i.e. 
reptilian) brain. It has been suggested that the formation of the endocrine pancreas and 
brain is an example of within-organism co-evolution, where beta-cells “provided an 
extra degree of freedom for the brain to evolve without having to think of getting 
energy supply” (Madsen 2007). 
 
Interestingly, cortisol and corticosteroid receptor evolution took place 450–500 
million years ago (Bury & Sturm 2007; Ortlund et al. 2007), coinciding with the 
evolution of brain and the endocrine pancreas. While it is highly unlikely that 
simultaneous evolution of beta-cells, brain, and stress response was a random 
coincidence, the present hypothesis links the three in a co-evolutionary manner. 
Evolution of the endocrine pancreas was not enough to protect the brain when the 
organism was stressed. Stress-induced insulin resistance allowed for preferential 
diversion of glucose to the brain during stress, provided that beta-cells lost part of 
their antioxidant defence. I therefore suggest that a weakening of antioxidants in beta-
cells occurred as brain, corticosteroid response, and beta-cells in the endocrine 
pancreas co-evolved. 
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According to my hypothesis, further reduction of the antioxidant defence in beta-cells 
occurred in females when placental mammals evolved approximately 100 million 
years ago (Kitazoe et al. 2007). Since both the initial and the later (sex-specific) 
reduction in the antioxidant status of beta-cells were associated with increased fitness 
of the whole organism, beta-cells (particularly in females) retained their weak defence 
to the present day. 
 
3.4      Predictions 
Table 3.2 summarizes the proposed life history explanation of the otherwise puzzling 
vulnerability of beta-cells and the predictions made by the hypothesis. It is proposed 
that beta-cells in female placental mammals lost even more of their antioxidant 
capacity in order to allow for proper nourishment of the foetus through the placenta 
during pregnancy. An intriguing prediction is that females and males were less 
different in terms of beta-cell antioxidants before the placenta evolved. A comparative 
study of a mammal species and a non-mammal vertebrate species can readily test this 
prediction though it should be noted that, among mammals, comparative studies are 
complicated by the need to take into account the well-established differences between 
species in the general strength of the maintenance and repair systems. Also, the 
current state of beta-cell structure and physiology in mammals is predicted to be 
evolutionary „younger‟ in females than in males. Finally, if beta-cells first lost part of 
their antioxidant system for the sake of the brain during stress, one could predict the 
existence of better protected beta-cells before the brain evolved. This period, which 
was probably relatively short in evolutionary terms, was the time of intestinal beta-
cells that monitored gut glucose. 
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Table 3.2: The proposed evolutionary history of beta-cells  
Time  Species  Evolutionary features 
> 500 million 
years ago 
Proto-chordates  No brain 
No cortisol/corticosteroid receptors 
Beta-cells in the intestinal tissue 
Beta-cells sensed gut glucose  
Beta-cell antioxidants normal 
Beta-cells in males equal to females   
450-500 million 
years ago 
Vertebrates  Evolution of the brain 
Evolution of cortisol/corticosteroid receptors 
Evolution of the endocrine pancreas 
Beta-cells sensed blood glucose 
Reduction in beta-cell antioxidants 
Beta-cells in males equal to females 
~100 million 
years ago 
Placental 
mammals 
Evolution of the placenta 
Further loss of antioxidants in beta-cells 
 
 
3.5      Natural selection: master of trade-offs 
If the hypothesis is correct, the model shows how antioxidant expression in beta-cells 
is optimized through an evolutionary trade-off which sacrifices some of the protection 
against ROS in order to facilitate the metabolic demands of stress in general and of 
pregnancy in particular. Expression of antioxidants needs to be above a certain 
minimum to neutralize the ROS produced as a by-product of glucose metabolism and 
to avoid their deleterious effects on cell survival, proliferation and function (i.e. 
glucose homeostasis). At the same time, antioxidant expression needs to be kept low 
enough to allow for the regulatory role of ROS. This explanation fits well the 
disposable soma theory where an evolutionary trade-off between investments in 
survival and reproduction is effected by optimising the respective allocations of 
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resources at the cellular level (Kirkwood & Holliday 1979). Given the importance of 
the evolving brain (in non-pregnant states) and the growing foetus (in mammals), it 
might have been worth investing less in somatic maintenance (e.g. antioxidant 
protection) and accept higher risks of oxidative stress-related problems (e.g. reduced 
beta-cell proliferation, survival and function), yet provide the brain and foetus with a 
reliable energy supply and avoid an otherwise inevitable compromise in times of 
stress. This can be achieved by insulin resistance-induced re-allocation of energy 
provided that the compensatory hyperinsulinaemia is unable to return glucose back to 
the set-point. Given that ROS have negative effects on insulin synthesis/secretion, I 
believe antioxidants in beta-cells are expressed at a sufficiently low level to allow for 
ROS to perform their important regulatory function during stress (including 
pregnancy). One would expect the evolutionarily most important tissues in the body 
to be insulin-independent. Taken together, antioxidants in beta-cells are expressed at a 
level sufficiently high to maintain the soma in a tightly regulated homeostatic 
environment, but low enough to contribute to the organism's fitness under stress and 
also to facilitate reproductive success.   
 
Without the existence of such a trade-off, it is hard to understand why natural 
selection would not have enhanced the weak beta-cell antioxidant system in females. 
In support of the hypothesis, it is notable that androgens (rather than oestrogen) 
provide some protection for beta-cells, by reducing mega-islet formation (Rosmalen 
et al. 2001) or apoptosis (Morimoto et al. 2005). The major drawback to a weak 
antioxidant system is a higher susceptibility of cells to oxidative damage, as occurs 
when there is sufficiently severe and prolonged exposure of beta-cells to an 
environment with high insulin demand. This, however, is much more commonly a 
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problem in today's world with abundant food, obesity, physical inactivity, and 
increasing life expectancy. In our evolutionary past, such factors would have been 
seen only rarely and they would not, therefore, have been important factors in shaping 
the evolution of the system and its regulatory balance (Kitano et al. 2004). 
Furthermore, completion of pregnancies would have allowed the temporary departure 
from homeostasis to be corrected before glucose levels could reach the diabetic range, 
even though pregnancy was more commonly experienced during an individual 
woman's lifetime in an era of much higher fertility than exists today. One can 
speculate that natural selection might be on its way to make further modifications to 
beta-cell physiology in response to the rather sudden changes that have recently 
occurred in our life styles. 
 
Why did natural selection select for organisms which had beta-cells with permanently 
reduced antioxidant defences, rather than those with beta-cells that were capable of 
tuning down their defence mechanisms only when encountering stress? In doing the 
latter, the organism could probably enjoy a lower life-time risk for development of 
type 2 diabetes because beta-cells would be more resistant to oxidative stress. It 
certainly requires more work before one can conclusively answer the question. 
Nevertheless, one can speculate that owing to a permanently weakened beta-cell 
antioxidant system, organisms were able to avoid the possible costs of a facultative 
antioxidant system, which could become significant if stress (e.g. pregnancy, 
infection) was a sufficiently frequent problem at the time of the evolution of the 
system.  
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For the following reasons, pregnancy has been an excellent opportunity for evolution 
to aid the mother in producing high-quality offspring. First, the relationship between 
the mother and offspring is never closer than it is in pregnancy. Second, pregnancy is 
a relatively long period of metabolic relationships between two genetically related 
individuals from successive generations. The maternal disadvantages associated with 
poorly protected beta-cells are offset, according to the hypothesis, by the resulting 
increments in offspring fitness. Adapting to pregnancy is indeed a prominent feature 
of mammalian evolution. Evolution of beta-cell antioxidant defences is a naive 
example of the link between antioxidant protection and reproductive success.  
 
I have discussed how pregnancy might have contributed to the evolution of a weaker 
beta-cell antioxidant system in female mammals. The above observations suggest the 
possibility of the HPA axis neonatal programming having some impact on beta-cell 
antioxidant responsiveness. Experimental evidence is to date lacking on this 
possibility. Although neonatal programming may have a fine-tuning effect on beta-
cell antioxidants, I believe this mechanism has not significantly influenced the 
evolution of beta-cell antioxidants. The proximate mechanism that down-regulates 
beta-cell antioxidants in females is not known at the moment. The time point during 
development (e.g. foetal period, perinatal period) when this modification occurs is 
also unclear. Sex hormones and changes in the intra-uterine environment are good 
candidates for future investigations. The connection between stress, pregnancy and 
beta-cell antioxidants becomes even more complicated when considering the 
reduction that occurs in HPA responsiveness to emotional and physical stressors in 
pregnancy (Neumann et al. 1998). It has been suggested that this mechanism might 
79 
 
have evolved to protect the mother and her foetus from excess corticosteroids 
(Weinstock 1997).    
 
3.6       Clinical implications  
Insulin resistance mediates the link between the signal (i.e. stress) and the appropriate 
response evoked in the stressed system, by an appropriate reallocation of energy 
resources (Figure 3.5). The ensuing glycaemia is sensed by beta-cells which, owing to 
the regulatory role of ROS, only partially correct it if the signal is sufficiently strong. 
The net additional amount of glucose which becomes available in the blood can 
subsequently be directed to insulin-independent tissues, the foetus in pregnancy and 
the brain otherwise. When the stress is removed, the system switches back to its 
original steady state. Pathology arises as a result of a failure in this last step (e.g. due 
to stress chronicity or severity). Type 2 diabetes is the ultimate outcome of an 
extremely complex interaction between various genetic and environmental factors that 
cause insulin resistance and beta-cell dysfunction. Therefore, the marginally higher 
prevalence of the metabolic syndrome and type 2 diabetes among males (Isomaa et al. 
2001) is not incompatible with the weaker antioxidant system in female beta-cells. 
 
The weakness of antioxidant defences in beta-cells along with the definitive 
contribution of oxidative stress to the pathogenesis of type 2 diabetes has provoked 
the idea of helping beta-cells better protect themselves against ROS to prevent 
development and progression of diabetes. This idea has been successfully tested in the 
lab (Yamamoto et al. 2008). Over-expression of thioredoxin, an antioxidant protein, 
in mouse beta-cells prevented progression of type 2 diabetes. This was associated 
with suppression of the ROS-induced reduction of PDX-1 and MafA expression in 
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beta cells. However, ignoring the evolutionary history of beta-cells and the adaptive 
mechanisms that drove their evolution may have undesired outcomes. In a system 
which has evolved under the influence of several trade-offs, trying to modulate one 
feature might leave the organism unfit in other functions. Without considering the 
evolutionary history of beta-cells, any attempt aimed at improving beta-cell sensitivity 
to ROS may result in compromised stress responsiveness and reduced reproductive 
success. It is in the nature of hypotheses that they do not prove that what they assert is 
the truth. Nevertheless, it is important that they should throw new light on existing 
data and necessary that they should be both plausible and amenable to experimental 
test. I believe that testing my hypothesis will lead to interesting and potentially 
valuable new insights into the factors that lie behind an important age-related 
condition.  
 
There are a number of mechanisms by which the system tries to resist chronic stress. 
Glucocorticoid secretion has a circadian rhythm. After each pulse of secretion, there is 
a refractory period during which the HPA axis is not activated by mild stressors 
(Windle et al. 1998). Therefore, with increased frequency of pulsatility due to chronic 
stress, the animal will spend more time in stress hyporesponsiveness (Windle et al. 
2001). Stress responsiveness is under both genetic (Windle et al. 1998) and epigenetic 
control. It is known that the HPA axis can be programmed by early life events (Levine 
1967). Perinatal exposure to stress makes animals more stress responsive in 
adulthood. The underlying mechanism seems to be related to increased frequency of 
HPA pulses and glucocorticoid pulse amplitude (Shanks et al. 1995; Shanks et al. 
2000). 
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Figure 3.5: The relation between stress and energy allocation. Insulin resistance 
mediates the link between stress and response. Glycaemia-induced ROS signal beta-
cells of the presence of insulin resistance, beta-cells partially correct the glycaemia, 
and energy is re-allocated to different tissues as appropriate. The system fails to return 
to the original steady state if the stress persists for a long time. 
 
3.7       Beyond glucose homeostasis 
Further examples exist of reproductive success being enhanced at the expense of 
reduced protection against ROS. Birds that have higher reproductive success also 
have lower levels of antioxidant expression (Wiersma et al. 2004). In zebra finches, 
the number of eggs laid correlates negatively with resistance to oxidative stress 
(Alonso-Alvarez et al. 2006). As mentioned above, the disposable soma theory is built 
on such trade-offs.  
 
Oxygen radicals act in many systems as second messengers in signal transduction 
(Finkel 2003). Relevant to protein misfolding and protein aggregation diseases (e.g. 
Alzheimer disease), it has been shown that ROS are signals generated by misfolded 
82 
 
proteins in the endoplasmic reticulum that cause cell death (Malhotra et al. 2008). In 
addition, protein misfolding in the endoplasmic reticulum has been suggested to be a 
causative upstream event in insulin resistance (Ozcan et al. 2006). Mitochondrial 
oxidants act as facilitators of communication between the mitochondria and the 
cytosol compatible with an evolutionary adaptation following the ancient 
incorporation of mitochondria into eukaryotic cells (Nemoto et al. 2000). Why natural 
selection has so frequently chosen potentially dangerous molecules such as ROS for 
intracellular signalling may be explained by the fact that these molecules are 
inevitable by-products of cellular metabolism. By using ROS as signalling molecules, 
the system did not need to invent and pay additional costs for a distinct regulatory 
system.   
 
3.8      Robustness, homeostasis, and allostasis 
Robustness is an inherent, fundamental feature of complex biological systems and a 
milestone in the course of their evolution. Complete elimination of environmental 
perturbations, as occurs in homeostasis, is not always advantageous. Rather, 
maintenance of function in unstable environments frequently requires temporary or 
permanent departure from homeostasis. Under such circumstances, the fitness 
advantages of changing may outweigh those of remaining the same (Kitano 2004). 
The concept of robustness is being incorporated, using firm mathematical definitions, 
into our current understanding of fitness in biological systems (Kitano 2007). Natural 
selection appears to have used ROS, which tend to impair homeostasis in many 
systems, as regulatory molecules in beta-cells that help the organism appropriately re-
allocate the available energy resources under stress conditions. Corticosteroid 
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response to stress and ROS-regulated beta-cell reaction to the resulting insulin 
resistance act in harmony to protect the brain and foetus against hypoglycaemia.  
 
Homeostasis means remaining stable by staying the same, whereas allostasis refers to 
the process of remaining stable through change. Both homeostasis and allostasis are 
important for maintaining the stability of an organism (Fisher & Reason 1988). 
Allostasis makes the organism capable of actively adjusting in the long run to both 
predictable and unpredictable events. The costs of this long-term adaptation to stress, 
referred to as "allostatic load", is manifested as pathology (McEwen & Wingfield 
2003). The term "glucose allostasis" has recently emerged in the literature to explain 
the process by which prolonged environmental stress and the adaptations they 
provoke lead ultimately to severe insulin resistance and type 2 diabetes (Stumvoll et 
al. 2004). Stumvoll et al (2003) suggest that glycaemia is a signal to inform beta-cells 
of the presence of insulin resistance, that is to say, the organism is likely to be facing 
prolonged stress. There is strong observational evidence for the involvement of 
allostasis in the pathogenesis of type 2 diabetes (Stumvoll et al. 2003). My hypothesis 
demonstrates how beta-cell defence mechanisms might have evolved to confer the 
organism the ability to respond to stress in an optimal manner. The role of pregnancy 
as a common stress condition in the past 100 million years in shaping the evolution of 
the glucose homeostatic system should not be underestimated.  
 
3.9     Appendix: a model for the regulatory role of ROS 
Without losing generality, insulin and glucose are measured from their original pre-
pregnant set-points. The homeostatic value of glucose is therefore assumed zero and a 
specific value G for glucose means G units above the homeostatic set-point (units are 
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chosen arbitrarily). Let Irequired = kG represent the units of insulin required to remove 
G units of glucose from the blood. Thus, k provides a measure of insulin resistance. 
To account for the inhibitory effect of glucose-induced ROS on insulin, let Iactual = (k-
rG)G be the actual units of insulin following the exposure to G units of glucose. Here, 
-rG represents the inhibitory effect of glucose-induced ROS production on insulin 
synthesis/secretion. The emergence of the quadratic term -rG
2
 is consistent with the 
observation that if glucose exposure exceeds a certain level, insulin secretion becomes 
compromised, levels off, and eventually declines due to ROS-induced glucotoxicity 
(Brownlee 2003), as shown in Figure 3.6 (left). We add g units of glucose to the 
system at each step and simulate the model over time (Figure 3.6B right). 
 
             
Figure 3.6: The effect of ROS on glucose homeostasis. Left: Hypothetical insulin-
glucose curves with (solid) and without (dashed) ROS. Right: Departure from 
homeostasis due to the effect of ROS (units chosen arbitrarily). 
 
If r is zero (sufficiently strong antioxidant system in non-exhausted beta-cells), 
Irequired = Iactual and perfect homeostasis always takes place. Glucose concentration 
returns back to the set-point (thus lying on the horizontal axis), by proportionately 
adjusted insulin secretion. With larger values of r, however, the system gradually 
departs from homeostasis and glucose levels rise without beta-cells being exhausted. 
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If the desired degree of departure from homeostasis is known, one can theoretically 
work out how large an r is needed. Given the amount of ROS required, the strength of 
antioxidant system can eventually be estimated. 
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Chapter 4: A central role for stochasticity in evolution of asymmetric 
damage segregation: modelling and simulation 
4.1      Introduction 
All living cells contain an essential complement of molecular components which may 
acquire faults through errors in synthesis or processing or through the impact of 
damage, e.g. by oxidation, radiation or heat. In order to maintain viability, damage 
must be kept from accumulating beyond a level which threatens cellular survival. 
Sooner or later any individual cell will die, and so the continuation of life depends 
also on a cycle of cell growth and division, during which new molecular components 
are synthesised and new and old components are then divided among the daughter 
cells. Cell division itself acts as a mechanism to inhibit the accumulation of damage, 
provided that the dilution of damaged components with new ones is sufficient to 
prevent a generation-to-generation increase in the level of damage. Where cells divide 
symmetrically to form two essentially identical daughters, it is simply required that 
damage should not accumulate faster than it is diluted (or removed by repair). It may 
however be possible to enhance the maintenance of a lineage by segregating damage 
asymmetrically so that one daughter cell remains relatively free from damage, while 
the other is burdened with the majority of damaged components from the parent. 
There are many examples where cell division occurs asymmetrically, especially in 
multicellular organisms but also in unicellular organisms like the yeast 
Saccharomyces cerevisiae. There has been growing interest in the possible benefits of 
asymmetric damage partitioning, particularly in relation to the intrinsic biology of 
cellular ageing (Ackermann et al. 2003; Johnson & Mangel 2006; Kirkwood 2005). 
Experimental data and in silico models suggest that damage segregation in unicellular 
organisms is a strategy that favours rapid growth (Watve et al. 2006; Evans & 
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Steinsaltz 2007), helps the single-celled organism cope with damage (Johnson & 
Mangel 2006; Ackermann et al. 2007; Fredriksson & Nyström 2006), and allows the 
lineage to withstand higher levels of damage before entering clonal senescence 
(Erjavec et al. 2008).  
 
An important aspect of how damage arises and may affect cells concerns the role of 
intrinsic chance. Most individual instances of damage arise randomly even though the 
level of exposure to damage and rate of repair may be regulated. The segregation of 
damage at cell division may also be random, unless it is subject to some form of either 
constraint or control. This raises important questions of how stochastic variation not 
only affects the partitioning of damage but may also interact with the forces of natural 
selection that might have acted to influence the evolution of adaptive strategies for 
damage segregation. Stochastic effects are more pronounced in smaller systems 
(Spudich & Koshland 1976) so there is also a relationship with size both of the cell 
itself and also of the „unit‟ of damage. For example, proteins that are damaged and 
escape degradation tend to form relatively small numbers of aggregates (Carrió & 
Villaverde 2003; Maisonneuve et al. 2008), which may thus show larger statistical 
fluctuations during segregation, in terms of the proportions concerned, than if the 
same damaged proteins persisted without aggregation. The effects of stochasticity 
have not been sufficiently taken into account in previous work.  
 
Using a stochastic model, I examine the evolution of strategies and their 
consequences to segregate damage, taking account of another fundamental principle 
in living systems: the need to allocate resources between cellular maintenance and 
reproduction. My analysis suggests that a continuum of segregation strategies can 
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evolve in unicellular species and offers a link between the ecological circumstances 
under which organisms evolve and the intracellular events that contribute to the 
optimal level of segregation asymmetry. I highlight the central role of stochasticity in 
evolution of asymmetric damage segregation and explain a number of interesting 
experimental observations.  
 
4.2      Previous models 
Of the few previous modelling attempts on the subject of asymmetric damage 
segregation in unicellular organisms, I briefly mention the two most relevant and 
recent ones here. The model developed by Ackermann et al (2007) shows that the 
differential ageing of the parent and daughter cell (resulting in an old parent and a 
rejuvenated daughter cell) readily evolves as a strategy to cope with damage that 
accumulates due to vital activities. In this model, the authors assume a survival 
function, s(D), which determines the probability that a cell with damage D (inherited 
at birth from the parent) survives to next mitosis. The authors show that asymmetric 
distribution of damage is favoured over symmetry unless the survival function has 
substantial negative curvature. The model produces similar results when damage 
affects fertility rather than survival. In order to support their assumption about the 
curvature of the survival function, the authors used data from the bacterium 
Caulobacter crescentus and show that the survival function is linear to slightly 
concave up, thus supporting the prediction on evolution of asymmetry. Finally, the 
authors make an analogy between (ageing) parent/ (rejuvenated) offspring in 
unicellular organisms and soma/germ distinction in multicellular lineages. The 
multicellular parent retains the whole damaged soma, while the offspring is made 
from undamaged fresh germline.  
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Erjavec et al (2008) developed another interesting model to investigate potential 
advantages of asymmetric damage segregation in a unicellular lineage. The endpoint 
in their model was entry to clonal senescence, i.e. they were interested in knowing the 
conditions that delay clonal senescence. In addition to the level of damage segregation 
asymmetry, the authors also considered size asymmetry at the time of mitosis. The 
authors included in their model a critical number of intact proteins required for 
cytokinesis. Furthermore, they assumed that damaged proteins do not have any 
intrinsic toxicity. They only prolong the time required for the cell to accumulate the 
critical amount of intact proteins to undergo mitosis. Erjavec et al. show that 
asymmetric damage segregation is advantageous in a system producing different-
sized progeny only at high damage propagation rates. In contrast, asymmetric damage 
segregation enhances the fitness of a system of equal-sized progeny regardless of 
damage propagation rates. These findings suggest that asymmetry in damage 
distribution at mitosis is more universally advantageous than thought before, and 
should thus be expected to be more common.  
 
4.3      Structure of the Model 
I assume a population to comprise initially 1,000 unicellular organisms. There is no 
spatial or hierarchical structure within the population and organisms do not interact 
directly with one another. However, competition for the limited resources which are 
available in the environment increases the risk of death of organisms and provides a 
mechanism to put an upper limit, subject to stochastic changes, to the size of the 
population. The rate of resource replenishment is assumed to be limited and above the 
threshold required for survival of 1,000 individuals. Therefore, although the 
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probability of the population reaching a very large size is not zero, it becomes smaller 
and eventually approaches zero as the population expands beyond its initial size of 
1,000. The environment is otherwise stable and does not undergo perturbations. The 
population grows by cellular proliferation and declines by death of individual cells. 
Proliferation is a time-dependent process in this model. The chances that a cell 
proliferates are minimal when the cell is formed and increase with time. Two daughter 
cells arise from a cell proliferation and divide all the materials that exist in their 
mother between each other. A daughter cell may differ from its mother in genetic 
and/or non-genetic materials (see below). Extrinsic death occurs because of the 
competition for limited resources and depends in this model on the population size; 
the risk per cell of extrinsic death is greater at larger populations. The probability of 
intrinsic death increases with accumulated damage in the cell. Cell death is assumed 
to occur by an apoptotic-like mechanism which removes the cell without affecting 
other cells.  
 
By damage, I refer throughout the model to irreversible non-genetic damage. The 
damage status of each cell at a given time is defined as the total number of units of 
damage that has accumulated in the cell until that time. One unit of damage is defined 
as all damaged molecules that inevitably have the same fate, that is to say, because of 
being within an aggregate are all inherited by one of the daughter cells. Damage 
accumulation in the cell, like other processes in this model, is a stochastic process. 
The cells are assumed to have already identified via evolution the optimal portion of 
resources to invest in maintenance and reproductive functions. The population 
therefore remains homogenous in terms of the efficiency of either function and the 
parameters controlling the rates of damage accumulation and proliferation are 
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assumed similar for all cells. Nevertheless, I investigate the effects of different 
resource allocation strategies on the outcomes of the model in the analysis step.  
 
The way damage is segregated at division between the two daughter cells is 
considered to be a genetically coded trait. I assume, for simplicity, that the organisms 
are haploid asexual and a single gene in a single locus is responsible for the 
segregation trait. Segregation can be completely symmetric in which case each unit of 
damage is inherited by a given daughter cell by a probability of 0.5. It can be 
completely asymmetric, and all damage units segregate into one of the daughter cells. 
It might also lie anywhere between complete symmetry and complete asymmetry, e.g. 
each damage unit having 0.75 chance of ending up in one daughter cell and 0.25 
chance of ending up in the other. The segregation allele is subject to mutations. 
Mutations occur randomly and may increase or decrease the value assigned to the 
allele.            
 
4.4      Methods  
4.4.1   Events and formulations 
There are five events in the model: i) extrinsic death, ii) proliferation, iii) damage 
accumulation, iv) intrinsic death, and v) mutation. Let us focus on a particular cell 
(cell i). Suppose the latest event in the population has occurred at time t, measured 
from the time of formation of cell i. Also assume that cell i is the cell to undergo the 
next event in the population and that event is to occur at time t + ∆t. I will later 
explain how I determine the cell which is to experience the next event and also how I 
calculate the time interval between two successive events. Let Dn(t) denote the 
number of units of damage that exist in cell n (n =1, 2,…, N (t)) at time t. N(t) is the 
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size of the population (the number of living organisms in the population) at time t. 
The probability, Pi,D(t + ∆t), of cell i having D units of damage at time t + ∆t is equal 
to the probability, Pi,D -1(t), of the cell having D – 1 units of damage at time t 
multiplied by the probability that damage accumulation (event iii) is the event chosen 
(among all five possible events) to occur at time t + ∆t in cell i plus the probability, 
Pi,D(t), of the cell having D units of damage at time t multiplied by the probability that 
an event other than damage accumulation is chosen to occur at time t + ∆t in cell i. In 
other words 
  
Pi,D(t + ∆t) = Pi,D -1(t) × P(next event is iii) + Pi,D(t) × P(next event is not iii) 
= Pi,D -1(t) × h3(t) / hT(t) + Pi,D(t) × (1 - h3(t) / hT(t))  
= (Pi,D -1(t) - Pi,D(t)) × h3(t) / hT(t) + Pi,D(t)  (1)   
 
where 
hT(t) = h1(t) + h2(t) + h3(t) + h4(t) + h5(t)  
 
is the total hazard at time t and hk(t) (k = 1, 2, 3, 4, 5) is the hazard or propensity of 
event k at time t. The hazard function for a given event divided by the sum of all 
hazard functions (other events) represents the probability of occurrence of that event 
as the next event. The value of a hazard function, in biochemical terms) depends on 
the number of reactants and the rate constant for the specific reaction. More generally, 
reactants in our context can be molecules, cells, organisms, etc. As explained below, 
the hazard value for intrinsic death (event iv) is cell-specific. In order to avoid 
confusion and for more clarity, however, I drop the otherwise extra index i from h4(t).     
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I now define the hazard functions for each of the five events. Since I am assuming 
that the optimum resource allocation strategies are established in the population and 
thus cells are investing constant amounts in maintenance/repair and reproductive 
functions, I consider simple constant hazard functions h2(t) = m and h3(t) = d for 
proliferation (event ii) and damage accumulation (event iii), respectively. The hazard 
function for mutation is also assumed to be time-independent constant, h5(t) = p. By 
intrinsic death (event iv), I refer to death due to accumulated damage. The simplest 
case of an ascending function in the form h4(t) = D(t ) × μi is assigned to intrinsic 
death, where D(t ) is the number of units of accumulated damage in the cell at time t 
and μi is a constant parameter. The risk of extrinsic death (event i) increases as the 
population grows. I assume the hazard function for this event to be similar for all 
organisms and for a given cell increase linearly with the population size, i.e. h1(t) = 
N(t ) × μe, where μe is a constant parameter. If proliferation and extrinsic death had 
been the only events in the model, the total hazard of death across the population 
would have become N(t ) × N(t ) × μe , reminiscent of the quadratic term that serves to 
restrict the growth of the population in classical deterministic models of population 
growth (May 1976). The simplistic assumptions made to define hazard functions can 
be relaxed and more sophisticated functions may be selected without affecting the 
general patterns of the results. Taken together, equation (1) can be written as  
 
Pi,D(t + ∆t) = Pi,D(t) + (Pi,D -1(t) - Pi,D(t)) × d / (N(t )μe+ m + d + Di(t )μi + p) (2)  
 
Equation (2) describes the likelihood that cell i contains a given amount of damage at 
the time of next event. A properly designed dice, for example, may now be used to 
determine the time course of damage in the cell. Since the level of damage in a given 
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cell is known by equation (2), we can easily follow that cell until it dies or 
proliferates, owing to the fact that intrinsic death is the only damage-dependent event 
in the model. 
 
4.4.2 Implementation and simulation 
Simulation of the stochastic model was carried out using the Gillespie algorithm for 
coupled biochemical reactions (Gillespie 2007). Originally developed to simulate 
reactions within cells where the number of reactants are small, the algorithm has 
proved useful in simulating stochastic systems that extend beyond single cells. The 
main advantage of the Gillespie algorithm is that it does not require the presence of 
large numbers of reactants which is an essential assumption in continuous 
deterministic models that use systems of differential equations. Events are modelled 
in this algorithm as reactions, and each reaction is assigned a parameter (e.g. μe) using 
which the hazard function for that event can be calculated at each instant of time. 
Events and their corresponding hazard functions for the present model are provided in 
Table 1. None or at most one of the possible events (here extrinsic death, 
proliferation, damage accumulation, intrinsic death, or mutation) can occur to a cell at 
a given time.  
  
Table 4.1. Events and their hazard functions for one cell 
No. Event Definition Parameter  Hazard 
(propensity) 
   i Extrinsic death death due to cell-cell competition for limited 
resources, due to release of toxic materials by 
neighboring cells, etc 
μe N × μe 
ii Proliferation cell division (mitosis)   m m × t 
iii Damage  accumulation of one unit of damage   d d 
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 t: chronological age of the cell measured from its formation; N: population size; 
D: accumulated damage in the cell 
 
The Gillespie algorithm is a variant of a dynamic Monte Carlo method and is based 
on the following steps:  
1) Initialization: definitions and the initial conditions required for simulation of 
the algorithm are set in this step. A value σ (segregation coefficient) was assigned to 
the gene coding for the segregation trait. σ is allowed to range between 0.5 (complete 
symmetry; a given unit of damage goes into a given daughter cell with a probability 
of 0.5) and 1.0 (complete asymmetry; all damage segregate to one of the daughter cell 
cells). Initially, σ was set at 0.5 for all cells. I made this assumption to investigate the 
conditions in which selection for asymmetry would cause σ to depart from 0.5. It was 
assumed that initially no damage existed in the cells. In order to model mutations, 
random numbers were taken from a normal distribution. The mean and standard 
deviation of this distribution were set at zero and 0.01, respectively. Depending on the 
sign of each mutation, the segregation trait can become more or less asymmetric. The 
initial size of the population was set at 1,000. 
2) Monte Carlo step: the time to the next event is a random number drawn from 
an exponential distribution with parameter equal to the total hazard in the system. The 
exponential distribution is without memory, i.e. the state of the system at any given 
time depends, in a probabilistic manner, only on its state at the previous time point.  
Now I come back to the question of how the next event and the cell to experience that 
event are chosen. First, I choose the cell. The probability that cell j (j = 1, 2,…, N) is 
selected for the next event is  
iv Intrinsic death death due to the accumulated damage μi D × μi 
v Mutation mutation in the segregation coefficient   p p 
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hT, j / (hT, 1 + hT, 2 + ….+ hT, N) 
 
, where hT, k is the total hazard of events for cell k, if it is chosen for the next event (k = 
1, 2,…, N). After the cell has been chosen, it is straightforward to choose the next 
reaction based on the hazard of each reaction relative to the total hazard in the 
selected cell, i.e. hj / (h1 + h2 + h3 + h4 + h5) for event j (j = 1, 2, 3, 4, 5). If the next 
event to occur is proliferation (event ii), then the number of units of damage that 
segregates at division into a given daughter cell should be determined. I chose 
segregation of damage to occur in a probabilistic manner and according to a binomial 
distribution with parameters D (number of units of damage in the dividing cell) and σ.  
3) Update: hazard functions are updated after each event. 
4) Iterate: the algorithm is repeated from step 1 until there remains no cells in the 
population or the experimenter stops the algorithm.  
 
The simulations were continued until the average σ stayed within an interval of length 
0.05 for at least 1,000 generations. This process typically required monitoring the 
population for approximately 200,000 generations.   
 
Cells gradually move on the fitness landscape and the distribution of different 
segregation strategies as the population reaches the steady state approximately reflects 
the successfulness of each strategy. In order to monitor the evolution of segregation 
strategies with time, σ is averaged over the population. Using the mean of σ, rather 
than its median, as a measure of central tendency represents a “worst- case scenario” 
approach for evolution of asymmetry because it turns out that after the population has 
settled into a steady state, segregation strategies tend to have negatively skewed 
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distributions where median is larger than the mean. The code for the simulation 
algorithm was written in Python 2.5 and simulation results were plotted in 
Mathematica 5.2.  
 
4.4.3    Regression analysis 
In order to determine the role of resource allocation trade-offs in the evolution of 
asymmetry, I focused on two parameters of the model: m as a positive correlate of 
reproductive investments and d as a negative correlate of maintenance investments. 
Together with μi as a measure of damage severity, m and d were included in a 
regression model. A total of 100 triplets of the form (m, d, μi) were randomly selected 
from the parameter space (the unit cube) and used for analysis. An arbitrary criterion 
was used to classify the outcome of evolution in two categories symmetry and 
asymmetry. This was done according to the population-averaged σ; values above 0.8 
were defined as asymmetry and those under 0.8 were regarded as symmetry. Although 
smaller values could also be considered as the cut-off point, I chose a rather high cut-
off point in order not to misinterpret symmetric cases as asymmetric. This definition 
represents another “worst-case scenario” for the evolution of asymmetry in the 
present study. The outcome of evolution was the dependent variable in the regression 
model to be predicted by a set of appropriately chosen predictors. Linear 
combinations of the three parameters as well their first-order interaction terms (e.g. d 
× m) were considered as predicting variables. The simplest model which yielded R
2
 > 
90% was selected. The predictors that exist in this model will therefore explain more 
than 90% variation in the outcome of evolution.  
 
4.4.4 Evaluation of fitness effects of asymmetry and their determinants 
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In order to determine the effects of asymmetry on individual fitness, simulations were 
repeated without mutations (p = 0). Therefore, the population is initially genetically 
homogenous and remains homogenous over time. The population was followed for 
one population doubling, and the required time was used as a measure of growth rate 
and hence fitness. Next the three potential determinants of asymmetry (m, d, μi) were 
manipulated and the results were compared. The average of 1,000 simulations was 
used for each fitness measurement.       
  
4.5      Results  
In this model, there is stochasticity in the segregation of low numbers of damage 
units, in determining inter-event time intervals, and in determining the next event to 
occur at each time step. As a result, the population-averaged σ moves along noisy 
trajectories (Figure 4.1A), as the population size approaches and eventually fluctuates 
around the carrying capacity of the environment (Figure 4.1A, inset). When the force 
of selection for evolution of asymmetry is not sufficiently high (i.e. the effects of 
asymmetry on fitness are not significant), segregation strategies undergo neutral 
evolution by random drift and the population-averaged segregation coefficient will 
approach 0.75. In spite of stochasticity, σ consistently approached a plateau 
throughout simulations. The plateau level was affected by choice of parameter values 
(see below), but was rather robust to noise-induced differences between successive 
runs of the model with similar parameters and initial conditions (Figure 4.1A). In 
previous models which allowed for segregation traits to arise as an emergent property 
of evolution (Ackermann et al. 2007), the outcome of evolution for all cells was 
complete asymmetry (σ = 1). Using the same approach but within a stochastic 
framework, I observed the evolution of strategies including but not limited to 
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complete asymmetry. The steady state distribution of segregation strategies in the 
population was a left-skewed distribution with a long tail towards symmetric 
strategies (Figure 4.1B), indicating considerable variation. This variation persisted 
regardless of the number of generations for which the population was followed. The 
observation that steady state distributions for segregation strategies are left-skewed 
reflects selection for asymmetry. 
 
Figure 4.1: Simulation results. (A) Three runs with identical initial conditions 
(explained within the text) and parameter values (μe = 0.001, m = 0.7, d = 0.8, μi = 0.2, 
p = 0.01). The parameters denote extrinsic death rate, proliferation rate, damage 
accumulation rate, and intrinsic death rate, respectively. The population-averaged 
segregation coefficient approaches a plateau. Damage severity, damage accumulation 
rate, and the proliferation rate are determinants of the level of the plateau. The inset 
demonstrates stochastic fluctuations of the population size (N) around its mean over 
time. (B) Histogram of segregation coefficients at steady state (σ = 0.84 ± 0.13), 
exhibiting considerable variation. The average of three simulations was used to 
produce the histogram.   
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In binary logistic multivariate regression analysis various combinations of d, μi, and m 
were considered as continuous  potential predictors of asymmetry. Asymmetry was 
the dependent variable and the outcome of evolution for the population. Asymmetry 
was coded as 1 (population-averaged segregation coefficient greater than 0.8) or zero 
(population-averaged segregation coefficient less than 0.8) in the binary logistic 
regression model. The simplest model (i.e with the smallest number of predictors and 
lowest order of interaction terms) which was capable of explaining more than 90% 
variation of the outcome of evolution (R
2
 = 0.91) was composed of d, m, and the 
interaction term d × μi. Specifically, large values of d (P = 0.008) and d × μi (P = 
0.016) and small values of m (P = 0.009) were significant predictors of asymmetry. 
Figure 4.2 shows the parameter values for which the outcome of selection is 
asymmetry. In particular, the distance between neighboring curves in Figure 4.2A, 
4.2B or 4.2C is a measure of the sensitivity of selection to the missing parameters in 
that panel. Therefore, selection is most sensitive to d. The interaction term d × μi in 
the regression model shows that the sensitivity of selection to d increases with 
increasing values of μi. Similarly, the sensitivity of selection to μi increases with 
increasing values of d. This can be seen in Figure 4.2B and 4.2C where the distance 
between neighboring lines increases with increasing values of μi and d, respectively. 
In summary, high rates of damage accumulation (i.e. high values of d) and severe 
damage with sufficiently detrimental effects on survival (i.e. high values of μi) 
promote the evolution of asymmetry, whereas rapid proliferation (i.e. high values of 
m) reduces the selection pressure.  
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Figure 4.2: Increase of the asymmetric trait from rarity. (A) The three-
dimensional panel A separates the region in which the corresponding parameter 
values allow for evolution of asymmetry from the region where the corresponding 
parameter values do not allow for evolution of asymmetry. (B-D) Panels B-D are two-
dimensional slices the three-dimensional surface in panel A. The missing parameter in 
panels B-D is given three fixed values. Parameter values below the lines in panels B 
and C, and to the right of the curve in panel D, allow for evolution of asymmetry. 
Increases in d (damage accumulation rate; panel B) and μi (intrinsic death rate; panel 
C) and decreases in m (proliferation rate; panel D) lead to expansions of the region for 
asymmetry at the cost of reductions in the region for symmetry. The distance between 
two neighboring curves in each panel is a measure of the sensitivity of selection to the 
missing variable in that panel. Selection is therefore most sensitive to d. Also, the 
sensitivity of selection to d increases with increasing values of μi and its sensitivity to 
μi increases with increasing values of d.       
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Figure 4.3 shows the effects of asymmetry on fitness. There are no mutational events 
and the growth rate of a genetically homogenous population (measured by its 
population doubling time) would show the fitness of the particular segregation 
strategy used by the individuals in that population. Using parameter values that 
promoted the evolution of asymmetry in mutation-prone and thus heterogeneous 
populations, asymmetry has clear beneficial effects on individual fitness (curves A 
and D). These effects were significantly diminished (curve B) or even completely 
abolished (curve C) when using parameter values that reduced the force of selection 
for asymmetry in mutation-prone populations. A significant proportion of individuals 
in mutation-prone populations do not follow the fitness-maximizing level of 
asymmetry (as predicted by individual fitness) after the population has reached steady 
state distributions of segregation strategies (compare Figure 4.1B and curve A in 
Figure 4.3 with similar parameter values and initial conditions). In particular, the 
proportion at steady state of individuals with a completely asymmetric strategy (σ = 1) 
never exceeded 25% in my simulations. 
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Figure 4.3: Fitness effects of asymmetry as measured by growth rates of 
genetically homogenous populations determined through simulations without 
mutations. Growth rates in each curve are normalized by the highest rate. (B vs. A) 
Increasing m reduces the effects of asymmetry on fitness. (C vs. A) Decreasing d 
reduces the effects of asymmetry on fitness. (C vs. D) Decreasing μi reduces the 
effects of asymmetry on fitness. The steady state distribution of segregation strategies 
for the same four sets of parameters as in Figure 4.3 is shown in Figure 4.4. 
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Figure 4.4: Steady state distribution of segregation strategies for the same four 
sets of parameters as in Figure 4.3 (A: d = 0.8, μi = 0.2, m = 0.7; B: d = 0.8, μi = 
0.2, m = 0.9; C: d = 0.5, μi = 0.2, m = 0.7; D: d = 0.5, μi = 0.5, m = 0.7). (B vs. A) 
Increasing m (proliferation rate) in this case does not have a significant effect on the 
steady state distribution of strategies because for high values of d (damage 
accumulation rate), selection is much more sensitive to d and μi (intrinsic death rate) 
than to m. (C vs. A) Decreasing d reduces the frequency of the completely 
asymmetric strategy (σ = 1.0) and decreases the skewness of the histogram. (C vs. D) 
Decreasing μi has a similar effect to decreasing d.   
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4.6       Discussion 
The results of the present study are original in several aspects. The outcome of 
evolution in previous deterministic models has been σ = 1 (Ackermann et al. 2007). 
My results represent a more realistic scenario in which the outcome of evolution 
depends on both organismal and ecological parameters and is not limited to complete 
asymmetry. S. cerevisiae and Schizosaccharomyces pombe (S. pombe) are examples 
of unicellular organisms that stand in two completely different positions on the 
asymmetry scale. While the former organism segregates damage using a segregation 
coefficient of approximately 0.75 (Aguilaniu et al. 2003), segregation of damage is 
very much symmetric (σ ≈ 0.55) in the latter (Minois et al. 2006). The present model 
is capable of accounting for this range. This study is also the first demonstration of the 
effects of the remarkable stochasticity that might have strongly influenced one of the 
most likely evolutionary origins of ageing, i.e. asymmetric segregation of damage 
(Kirkwood 2005; Lindner et al. 2008). Instead of having a single strategy (the optimal 
strategy) gradually moving to fixation we had a wide range of strategies at steady 
state. These less fit strategies spanned the symmetry-asymmetry continuum and 
persisted with time. As a result, complete asymmetry was never a strategy followed 
by more than a quarter of the population. The trivial explanation for this interesting 
observation is that mutations play a scattering role and as soon as natural selection has 
removed less fit strategies from the population, new mutations have brought about the 
same strategies in other individuals. The second possible explanation for why the 
percentage of individuals with complete asymmetry does not get arbitrarily large 
(even though asymmetry might be the best strategy under certain conditions) concerns 
the high risk of damage-induced death in half the progeny of completely asymmetric 
individuals. Specifically, if the rate of damage accumulation is high enough, 
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individuals with highly asymmetric strategies are at serious risk of losing half of their 
progeny whereas less asymmetric individuals may manage to do better. Finally, given 
the risk of death depends on damage and different strategies lead to different amounts 
of damage in their followers, the fitness of one strategy may depend on the frequency 
of that strategy as well the frequency of other strategies in the population (frequency-
dependent selection).    
 
I determined the contribution of key factors such as proliferation rate, damage 
accumulation rate, and damage severity to the evolution of asymmetry. Without 
sufficiently rapid accumulation and severe effects on survival, damage cannot 
generate enough pressure to promote the evolution of a new trait, i.e. asymmetry. 
Likewise, rapid proliferation allows the cell to free itself of damage by passing it to 
the next generation before damage can reach critical levels to threaten survival. 
Finally, the model provided in this study provides a generic framework into which 
additional parameters may be incorporated in future. Examples of such parameters are 
environmental perturbations, repairable forms of damage, sexual reproduction, 
spatially structured populations, direct cell-cell interactions, and resource flux into the 
environment.  
          
4.6.1    Asymmetry and trade-offs in resource allocation 
Limited resource availability generates a well-known trade-off between investments 
in reproduction and maintenance/repair (Stearns 1976; Fischer et al. 2009). More 
investment in reproduction by a binary dividing unicellular organism translates to 
more rapid proliferation, whereas more investment in maintenance/repair functions 
reduces the rate of damage accumulation. I showed that rapid proliferation and low 
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rates of damage accumulation reduce the selection pressure for asymmetry. Taken 
together, it can be expected that the trade-off between reproductive and maintenance 
investments would render the selection forces less sensitive to the exact investment 
strategy. Also, since damage accumulation is the product of the incoming stress and 
the strength of cellular defence/repair systems, the impact of alterations in the 
environmental stress on asymmetry will be major and dominant (Figure 4.5).  
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Schematic diagram showing various trade-offs affecting the evolution 
of asymmetry. There is a trade-off between investments in reproduction and 
maintenance/repair, and the model predicts that investment in either function acts to 
reduce the selection pressure for asymmetry. Selection will then be less sensitive to 
the exact investment strategy. Since damage accumulation is the product of the 
incoming stress and the strength of cellular maintenance/repair systems, the impact of 
alterations in the environmental stress on selection pressure will be major and 
dominant. 
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In support of this prediction, treatment of S. cerevisiae with paraquat (an oxidizing 
agent) increased the asymmetry in segregation of carbonylated (a type of irreversible 
oxidative damage) proteins (Aguilaniu et al. 2003) (Figure 4.6A). The long-term role 
of the ecological niche on evolution of segregation strategies with different levels of 
asymmetry remains to be seen.  
 
 
 
 
 
 
 
 
 
Figure 4.6: Experimental evidence for different levels of segregation asymmetry. 
(A) Treatment of S. cerevisiae with paraquat (400 µg/ml) for 20 minutes increased the 
asymmetry in segregation of carbonylated proteins (adapted from (Aguilaniu et al. 
2003)) (B) In a total of 347 mitoses monitored in an experiment on S. pombe, there 
was no correlation (r = 0.021; P value = 0.692) between the segregation coefficient 
and the level of carbonylated proteins that existed in the mother cells undergoing 
mitosis (adapted from (Lindner et al. 2008)).   
 
If asymmetry is a way to resist deleterious environmental circumstances, then 
mutations that promote asymmetry will be favoured in harsh environments. For the 
same reason, asymmetry might be an alternative strategy to heavy investments in 
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maintenance functions, thus providing a higher proportion of resources for 
reproduction. If this prediction is correct, one could then expect the asymmetric S. 
cerevisiae to have smaller maintenance investments and thus be less stress resistant 
than the symmetric S. pombe. Making such comparisons between these two species is 
not easy, given that their ancestors diverged more than 500 million years ago and are 
therefore evolutionarily rather distant (Heckman et al. 2001; Hedges 2002; Lum et al. 
1996; Sipiczki 2000). Nevertheless, the existing evidence supports my prediction. 
Cadmium (Cd
2+
) is a heavy metal which exerts its toxicity to the cell through reactive 
oxygen species generation, among other mechanisms (Vallee & Ulmer 1972). The 
subsequent oxidative stress can damage cellular components. Yeast responds to the 
Cd
2+
 stress by enhancing the
 
activity of cellular defence mechanisms. Enhanced 
synthesis of glutathione (GSH) and phytochelatins are examples of such mechanisms 
to immobilize the toxic metal ions (Mehra & Winge 1991; Perego et al. 1997; Perego 
& Howell 1997). Interestingly, S. pombe has been shown to use both GSH and 
phytochelatins to resist Cd
2+
 stress, whereas S. cerevisiae only uses the latter. 
Consequently, S. pombe shows much higher Cd
2+ 
tolerance than S. cerevisiae (Bae & 
Chen 2004). The segregation coefficient used by Candida albicans was identified 
very recently. This organism uses an asymmetric strategy (σ = 0.65) for segregation of 
irreversibly damaged proteins (Fu et al. 2008). By the same lines of arguments as 
above, we may predict higher maintenance investments made by Candida albicans 
than by S. cerevisiae. Indeed, the former organism is known to enjoy a significantly 
higher heavy metal resistance than the latter (Weissman et al. 2000; Wang & Chen 
2006). However, one should keep in mind the very different ecological conditions in 
which Candida albicans (a pathogenic fungus adapted to host defences) and S. 
cerevisiae have evolved. Further experimental evidence for predictions of the model 
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concerning the effects of asymmetry on evolution of resource allocation trade-offs 
requires more comparative research.  
 
4.6.2    Ecological aspects for the evolution of asymmetry    
In variable environments, genes that enhance phenotypic plasticity may be favoured 
over ones that result in a fixed response (Fischer et al. 2009; Agrawal 2001). Given 
the role of damage in promoting the evolution of asymmetry, one would expect in 
unstable environments that cells that are capable of increasing asymmetry in response 
to high levels of damage would be fitter than those adopting a constant segregation 
strategy (provided that the costs associated with plasticity are not too high). This 
facultative strategy offers an explanation for the observation that transient treatment 
of S. cerevisiae with oxidative stress increased the asymmetry in damage segregation 
(Figure 4.6A) (Aguilaniu et al. 2003). In contrast, S. pombe does not change its 
symmetric segregation strategy with varying levels of damage. In a total of 347 
mitoses observed in an experiment on S. pombe, there was no correlation (r = 0.021; P 
= 0.692) between σ and the level of carbonylated proteins that existed in the mother 
cells undergoing mitosis (Figure 4.6B) (Minois et al. 2006). The presented model 
would support a prediction that S. cerevisiae evolved in a relatively unstable 
environment, while the environment in which S. pombe evolved has probably been 
more stable. 
 
The ability to respond adaptively to environmental changes requires a certain level of 
complexity. When change is rare, populations may persevere by relying on rare and 
unpredictable mutations that arise over generations. Plasticity is not a superior 
strategy under these conditions (Pigliucci 2005). When change is frequent relative to 
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the lifetime of an organism, however, signalling pathways that convert environmental 
cues to an appropriate response may evolve. In effect, the resulting phenotypic 
plasticity regulated by signalling embodies within one organism the equivalent change 
one would expect to arise from mutations selected under more static environmental 
conditions. A signalling pathway, for example, would contain a component which 
detects macromolecular damage (resulting from environmental insults) and would 
then activate a downstream component which, through interacting with the 
cytoskeleton, could eventually orient the mitotic spindle and alter the way damage is 
segregated at division. One such pathway can be represented as damage-heat shock 
protein-glsA/rsp1p-cytoskeleton. Heat shock proteins, a large family of highly 
conserved and constitutively synthesized molecular chaperons, assist refolding and 
degradation of misfolded proteins, and may mediate the upstream part of the pathway 
(Bardwell & Craig 1984; P. Liang & MacRae 1997; Kültz 2003; Kültz 2005). Hsp70 
(DnaK) and Hsp104 (ClpB) are two widely studied chaperons that bind to irreversibly 
damaged (e.g. carbonylated) proteins (Erjavec et al. 2007; Zimmerman et al. 2004; 
Mogk et al. 1999; Hartl 1996; Barnett et al. 2005). On the downstream side, there are 
certain J domain proteins (e.g. rsp1p in S. pombe and glsA in the simple multicellular 
organism Volvox carteri) that form a bridge between heat shock proteins and the 
cytoskeleton (Zimmerman et al. 2004; Miller & Kirk 1999). Thereby, the signal (i.e. 
damage) can be converted to the appropriate response, i.e. the asymmetry level which 
maximally benefits the organism.  
 
4.6.3    Costs of asymmetry 
Repair of reversibly damaged macromolecules and degradation of irreversibly 
damaged ones are two principal ways used by cells to protect themselves against 
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deleterious effects of damage on survival. There are significant costs associated with 
possessing efficient repair/degradation systems (Kültz 2005). For instance, several 
steps in protein degradation and protein chaperoning depend on the hydrolysis of 
ATP, including the activity of 26S proteasome and Hsp70 (Babbitt et al. 2005; Hartl 
& Hayer-Hartl 2002). Chaperones such as Hsp70 are expressed at a high level and 
maintained at concentrations up to more than 1% of total cellular protein (Söti & 
Csermely 2007). Although chaperones have other functions as well in the cell, they 
are key players in detection of protein damage. The costs associated with maintaining 
the integrity and therefore the fitness of the cell have to be taken from the total energy 
budget of the cell and are therefore inevitably detracted from growth/reproductive 
capacity of the cell. Furthermore, these costs have to be paid by the same cell. 
Consequently, it would be worth investing in less costly alternatives if available. 
Asymmetry-generating mechanisms might be a suitable choice because the 
cytoskeleton, the primary requirement for asymmetric segregation of damage, has 
already had to evolve in order to provide the scaffolding for the cell. The same is true 
for many molecular chaperones that have several different functions in the cell. 
Furthermore, asymmetry is a way to get help from one‟s close relatives (e.g. one‟s 
daughter cells) in handling damage. A comprehensive understanding of how cells 
allocate their energy budget to maintenance and reproductive functions is not possible 
without considering asymmetry and its contribution to fitness. Chapter 5 describes a 
sophisticated analytical model for the evolution of asymmetry with the costs 
considered within the model.  
 
The intricate trade-offs that can be thought (as a result of this new perspective) to 
accompany the cells throughout their evolution may provide an explanation for the 
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observation that S. pombe opts for degradation rather than asymmetry for handling 
irreversible damage. One reason concerns the potential costs of evolving appropriate 
protein-protein interactions for the sophisticated asymmetry-generating machinery to 
work even though the raw materials for the system might have already evolved for 
other purposes. Selection in my model was only for, not against, asymmetry because 
asymmetry was assumed to be at no additional costs to the cell. The other reason 
underlying the S. pombe preference for segregation symmetry may be related to the 
size symmetry of this organism at division. If the size of the two daughter cells was to 
be kept equal (or near equal), asymmetric segregation of damage would pose an 
additional cost, other than its own associated costs, to the limited energy budget of the 
cell. The cell would then need to invent a likely different mechanism for asymmetric 
segregation of normal proteins in order to fill the daughter cell that received less 
damage. The important assumption behind this hypothesis is of course, that size 
symmetry per se was a major goal for the cell to keep unaltered.                
 
4.6.4    Future directions 
In this study, I showed that, at least in unicellular organisms, asymmetry and its 
associated consequences need to be taken into account when thinking about the fitness 
of cells. In particular, mechanisms responsible for generating segregation asymmetry 
may affect the way a cell chooses to allocate its metabolic budget to various 
functions. Furthermore, the trade-off between reproductive and maintenance 
investments renders the evolution of asymmetry sensitive to environmental factors. It 
was also shown that evolution of asymmetry is under the strong influence of 
stochasticity. I hypothesize that the variation of ageing phenotypes in multicellular 
organisms (Kirkwood et al. 2005) may have arisen through millions of years of 
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natural selection from the stochasticity that existed in the evolutionary origin of 
ageing. Whether and how the failure of model populations to achieve homogenously 
fit steady states (due to the continued presence of less fit strategies) can be linked to 
variations in the course of ageing in higher organisms is a potential area for future 
research.  
 
For multicellular organisms, embryonic development represents a stage where 
phenotypic plasticity has important and potentially lifelong effects and it is highly 
likely that an asymmetric segregation strategy will play a role. Recent evidence 
suggests that damaged proteins targeted for proteasomal degradation are 
asymmetrically distributed during mitosis in human embryonic stem cells (Fuentealba 
et al. 2008). Furthermore, there is emerging evidence for asymmetric segregation of 
damage during adulthood in higher eukaryotes. Irreversibly damaged proteins in 
Drosophila melanogaster neuroblasts and intestinal crypts of patients with protein 
folding disease are transported to accumulate in aggresomes at the microtubule 
organizing centre and then asymmetrically distributed to one of the daughter cells 
(Rujano et al. 2006). How asymmetric damage segregation which had already evolved 
in unicellular organisms for the benefit of the cell has been adapted by nature at 
transition to multicellularity remains to be seen. More discussion will follow in 
Chapter 5.  
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Chapter 5: An analytical model for the evolution of asymmetric 
damage segregation considering possible costs of asymmetry 
5.1      Introduction 
The ability of all forms of life, from simple unicellular organisms to complex 
eukaryotes, to continue to survive is closely linked to their ability to detect errors that 
occur in their macromolecules and then repair them. From an evolutionary 
perspective, the primary function of the maintenance systems is to provide a sound 
internal state as the organism grows and reproduces. The external environment, 
however, is not under control of the organism. Indeed, the environment is typically 
highly variable, harsh and stressful. One inevitable product of such environments for 
the organism is cellular damage which, if not properly countered, threatens the 
survival of the lineage in unicellular forms of life and the integrity of tissues in 
multicellular organisms. Unrepaired genetic damage is particularly dangerous because 
of its direct flow to future generations. Non-genetic damage (e.g. protein damage) is 
important too. When a cell divides at mitosis, all of its cytoplasmic materials, 
including damaged macromolecules are distributed during cytokinesis between the 
two daughter cells. Depending on its reparability, all or parts of damage may be 
further transferred to the next generation.     
 
How can a cell deal with damage and maximise its Darwinian fitness in environments 
with various sources of stress? Irreversible protein damage is a serious problem 
because the multitude of costly repair mechanisms that exist in the cell is of no use in 
this regard. The way this damage is inherited by the daughter cells is also important. 
Maximal dilution occurs with symmetric distribution of damage at division. In order 
to be effective, symmetry needs to be accompanied by sufficiently rapid proliferation 
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(Rashidi 2008). Otherwise, both daughter cells (i.e. the lineage) would suffer the same 
risk of accumulated damage rising eventually to a lethal level. Thus, symmetry is 
expected to be an efficient strategy to cope with irreversible damage when the 
environment is not too harsh, the cell is sufficiently rich in repair mechanisms, and/or 
proliferation is sufficiently fast. The advantage of making do with symmetry is that it 
does not require a separate and potentially costly mechanism to evolve. The 
disadvantage concerns the requirement for sufficient investment in maintenance (i.e. 
efficient repair) and/or reproduction (i.e. rapid proliferation). As an example, damage 
inheritance in the unicellular fission yeast Schizosaccharomyces pombe (S. pombe) is 
strikingly symmetric. The “old” daughter cell in this organism receives on average 
only 55% of maternal carbonylated proteins (Minois et al. 2006).  
 
In contrast, asymmetric segregation of damage favours the survival of a lineage by 
specifically promoting the survival of the daughter cell that inherits less damage. 
Sufficient asymmetry (one daughter cell is born with no damage in the extreme case) 
may guarantee lineage survival and compensate for slow reproduction and/or 
inefficient maintenance systems. Not surprisingly, asymmetric inheritance is prevalent 
in all kingdoms of life, from yeast to higher eukaryotes (Aguilaniu et al. 2003; Macara 
& Mili 2008; Rujano et al. 2006). The main issue with asymmetry is a potential need 
for specific mechanisms including new genes, molecules or interactions to evolve. It 
is not trivial to see what proportion of resources the cell is best to invest in 
maintenance, reproduction, and possibly asymmetry when resources are limited. 
Resource limitation causes a multitude of trade-offs at different levels (subcellular, 
cellular, organismal) to emerge (Fischer et al. 2009; Stearns 1976). Mathematical 
modelling is an alternative to the classical experimental approach in the study of these 
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trade-offs. Here I investigate and model the evolution of non-genetic damage 
segregation in unicellular organisms.     
          
5.2      The model 
5.2.1   Basic assumptions 
The model is based on a single haploid asexual cell which founds a genetically 
homogenous colony. Regarding damage accumulation and degradation, I study 3 
genes, each with one quantitatively identified locus. The quantitative value (s, ∆, g) of 
the genes (e.g. corresponding to their expression level) determines the strength of the 
particular traits they produce. The traits are protein synthesis rate, protein damage 
rate, and protein damage degradation rate, respectively. Since colonies are assumed 
genetically homogenous, I ignore rare mutations that might occur to the three genes of 
our interest. I am interested in damage only to the non-genetic materials inside the cell 
(e.g. proteins) and only irreversible types of damage (e.g. protein carbonylation 
(Stadtman 2006)). Proteins are synthesised at a constant rate s. A constant proportion 
of the existing proteins are assumed to become irreversibly damaged at rate ∆. While 
repair is the principal way by which cells handle reversible forms of damage, there are 
generally three ways to cope with irreversible damage: i) degradation (e.g. by the 
ubiquitin/proteasome system), ii) exocytosis, and iii) simply living with damage. With 
the latter, and if the cell survives to reproduce, damage may be diluted between the 
two daughter cells such that each inherits only part of the damage. The proportion of 
damage received by each daughter cell affects their chances for survival and thus their 
fitness (Ackermann et al. 2007; Evans & Steinsaltz 2007; Fredriksson & Nyström 
2006; Watve et al. 2006). This proportion may also influence the survival of the 
colony (Erjavec et al. 2008). For example, with sufficient asymmetry in segregation 
118 
 
of damage, the daughter cells in each generation which are born with relatively little 
damage can guarantee the survival of the lineage. The level of segregation asymmetry 
is assumed to be a heritable trait and rare mutations are not considered. I combine 
strategies (i) and (ii), collectively referred to as “degradation”. Reproduction takes 
place by cell division during which damaged particles in the mother cell are 
distributed between the two daughter cells. The timing of cell division depends on the 
amount of undamaged materials (in this model, native proteins) in the cell (Erjavec et 
al. 2008). When the number of native protein molecules reaches a certain threshold, 
the cell divides. If damage (D) increases beyond a fixed threshold D
*
, the cell dies. 
Death occurs by an apoptosis-like process and does not affect neighbouring cells.   
 
Fitness (of a cell) is defined as the number of descendants it produces per unit of time. 
The unit of time is arbitrary (as long as it is constant for comparison purposes) and 
can be defined large enough for cells to reproduce. I assume that the most primitive 
unicellular organisms had more symmetric damage segregation strategies than the 
more recently evolved cells. Therefore, the default strategy is assumed to be 
symmetric and I try to find triplets of the form (s, ∆, g) for which asymmetry pays. As 
a specific case, if all members of a colony that segregate damage symmetrically and 
descend from a given triplet survive, asymmetry will be associated with no fitness 
advantage and will thus not evolve. I develop the model in three successive steps. 
First, I assume that degradation mechanisms have not yet evolved. Next, I relax this 
assumption. In these two steps, the cell does not have to pay any costs (metabolic, 
energetic) to evolve asymmetry. In the third step, asymmetry is associated with a 
fixed cost detracted from resources invested in maintenance and/or reproduction.  
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5.2.2    Structure of the model 
There are 3 continuous-time processes (protein synthesis, protein damage 
accumulation, and damage degradation) and 3 instantaneous events (cell division, 
damage segregation, and cell death) in the model. The continuous-time processes are 
embedded in and modelled as the following 2 ordinary differential equations:  
 
gDpdtdD
psdtdp


/
/
            (3) 
 
Proteins (p) are synthesised at a constant rate (s) and are irreversibly damaged by a 
first-degree kinetic process with constant ∆. Damaged proteins (D) are also degraded 
by the same kind of process with constant g. The cell divides when normal proteins 
reach a threshold p
*
 unless damage has already reached a threshold D
*
 in which case 
the cell dies before division. Without loss of generality, let p
*
 = 1. Time (t) is 
measured from the time the cell separates from the mother cell and forms a new 
individual. In order to give our cells a chance to reproduce, I assume s > ∆. Without 
this assumption, the cell dies before it can divide. Segregation of damage at division is 
assumed to occur according to a segregation coefficient σ, which is a heritable trait. A 
proportion σ of damage segregates to one of the daughter cells and the rest of the 
damage goes to the other cell. To set the initial conditions, note that D(0) is the 
amount of damage that a daughter cell inherits from its mother. Since aggregation of 
damaged proteins makes them more stable (and so makes their turn-over slower than 
that of normal proteins), I do not consider the inheritance of normal proteins (Carrió 
& Villaverde 2003; Maisonneuve et al. 2008). In other words, let p(0) = 0.  
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5.3      Results   
5.3.1   No degradation 
In this case, corresponding to g = 0, the degradation mechanisms have not yet evolved 
or are negligibly primitive. The system has no fixed points (i.e. stable or unstable 
steady states) and the amount of accumulated damage increases in an explosive 
manner. The only chance for survival is rapid reproduction such that before damage 
reaches fatal levels, the cell has already divided.  
 
To examine the fate of the population and the advantages of asymmetry, let us look 
closely into the behaviour of the model. It can be shown that the necessary and 
sufficient condition for survival of a cell (until division) is 
 
)/1(1)0( 1* ssLnDD                 (4) 
The accumulated damage during a cell cycle is constant:  
 
)/1(1 1 ssLnx    
and (2) can be rewritten as:  
 
*)0( DxD   
Define d(0) to be the initial amount of damage in the founder cell. With that, three 
possibilities can be considered:  
 
(i) x < d(0): In this case, and as long as the cells follow a symmetric 
segregation strategy, the accumulated damage at the time of cell division 
declines with advancing generations and there is no death in the 
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population. Therefore, asymmetry cannot be associated with any fitness 
advantage in this situation.  
 
(ii) d(0) < x < D*/2: In this case, and as long as the cells follow a symmetric 
segregation strategy, the accumulated damage at the time of cell division 
grows with advancing generations to 2x < D
*
. Again, symmetry offers the 
highest possible fitness and there is no selection pressure for asymmetry.  
 
(iii) x > max{d(0), D*/2}: In this case, and with symmetry, the accumulated 
damage at the time of cell division grows with advancing generations to 2x 
> D
*
. If the younger daughter cells receive more than a proportion 
max{ ))0(/()0(,/)( ** xddDxD  }of maternal damage, the population 
will disappear at some point. Sufficient asymmetry enhances fitness and 
prevents the population from vanishing.  
 
5.3.2    With degradation 
Now I evaluate the case where cells already possess degradation mechanisms and 
hence g > 0. The cell cycle duration and total damage accumulated in the cell at time 
of division, if the accumulated damage is not high enough to have already killed the 
cell are given by 




/
1
)/1)(/)/()0(()(/)(
)/1(
g
T sgsgsDggsgD
sLnT
 
 
The analysis of the system shows that with sufficiently long cell cycle duration, the 
dynamics of the accumulated damage in a cell follows one of the following 3 patterns: 
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(i) Damage increases to a finite maximum. This case occurs when D(0) = 0.  
(ii) Damage decreases to a minimum. This case occurs when 
0)(/)0(  ggsD .  
(iii) There is an initial decline in damage after which damage increases to a 
finite maximum. This is the case for any condition that does not satisfy (i) 
and (ii).  
 
The system has one steady state )/,/(),( gssDp  , which is stable (Figure 5.1).  
 
      
Figure 5.1: The stable steady state of the system with three typical trajectories. 
The diagram shows the situation in the presence of damage degradation mechanisms. 
All trajectories are attracted to the steady state, shown by the dashed line. (A) The 
ratio of maintenance to growth investment is sufficiently high (g/s > 1/D
*
). (B) The 
maintenance/growth ratio is low (g/s < 1/D
*
). D
*
 is the death threshold for damage.  
 
Symmetry offers the highest possible fitness (all cells survive) when s < gD
*
. Also, 
symmetry is the best strategy (all cells survive) if both of the following two conditions 
hold (see Appendix for detailed analysis): 
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5.3.3    Costs of asymmetry 
In the previous two sections, I have implicitly assumed that asymmetry has no cost (in 
terms of available resources or energy budget of the cell) for the cell, that is, the 
molecules that may provide an asymmetry-generating mechanism have already 
evolved in the cell for other purposes and asymmetry is either a costless by-product of 
their existence or the costs to the cell of the new interactions that need to be created 
between those molecules are negligibly small. Now, I relax this simplistic assumption 
and analyse a case in which the total energy budget of the cell is allocated in an 
optimal fashion to three categories of physiological functions: maintenance (required 
budget: em), reproduction (required budget: er), and asymmetry (required budget: ea). 
There is no explicit mathematical formula to deal with this in a general way, so for 
tractability I only compare symmetry with complete asymmetry (σ = 1). In other 
words, I do not calculate the fitness conferred by partially asymmetric segregation 
strategies (e.g. σ = 0.8).  
 
I make two further assumptions: (i) the rate of damage accumulation is inversely 
related to maintenance investments (under constant environmental conditions), and 
(ii) the cell cycle duration is inversely related to reproductive investments (Figure 
5.2). Let us represent these two relationships with g(em) and f(er), respectively. 
Therefore, the amount of damage accumulated (and added to the initial damage the 
cell is born with) during a cell cycle will be g(em)f(er).  
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Figure 5.2: Fundamental relationships stemming from physiological trade-offs. 
A cell invests in reproduction and maintenance. (A) The proliferation rate increases 
and thus the cell cycle duration decreases with increasing reproductive investment. 
The cell cycle can become infinitely long (with little investment in reproduction), but 
due to physicochemical constraints it cannot be shorter than a certain minimum. (B) 
The rate of damage accumulation decreases with increasing maintenance investment. 
The environment is assumed as a finite source of stress such that damage 
accumulation cannot be infinitely fast, even when maintenance investment is minimal. 
A minimum rate of damage accumulation is inevitable, irrespective of the level of 
maintenance investment. 
 
It can be shown that with a symmetric segregation strategy, every cell in the 
population survives to reproduce if  
)}0(,2/min{)()( ** DDDefeg rm   
 
Consequently, the highest possible fitness with symmetry is achieved by  
)}}0(,2/min{)()(:min{)( ** DDDefegeopte rmmm   
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(Figure 5.3) and the fitness (population size at time t) associated with this optimal 
strategy will be 
fitnessmax = 
))((/
2
opteeft m                 (4) 
 
 
Figure 5.3: The condition in which symmetry offers its highest possible fitness 
advantage. Maintenance investment needs to be set at the lowest value for which the 
amount of damage accumulated during a cell cycle is less than a certain minimum 
(shown by the solid horizontal line).  
 
With (complete) asymmetry, the amount of damage in a given cell increases to the 
time of division and then completely segregates to one of the daughter cells. As a 
result, one can trace the original cell through generations. When damage reaches the 
fatal threshold D
*
, the cell dies. Therefore, a cell lives for a certain number, l, of 
cycles that depend on its initial damage, the fatal damage threshold, and the amount of 
damage accumulated in each cell cycle. We have 
 
)]()(/))0([( * rm efegDDl   
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, where [u] is the largest integer smaller than or equal to u. For example, if the 
accumulating damage kills an initially damage-free cell (i.e. its old daughter cell in 
this example) during its second cell cycle, l will be 1 and the population size at any 
time (after the first cell cycle is completed) will be 2. Compared to the symmetric case 
discussed above, this is a considerably low fitness value. When l = 2 (i.e. damage kills 
a granddaughter of an initially damage-free cell), it can be shown that  
 
))()((2)1( nNnNnN d                (5) 
, where N(n) and Nd(n) denote the total number of living cells and the number of cells 
that die in generation n, respectively. Further analysis shows that Nd(n) is a Fibonacci 
number and hence  
5/))1(()( 11   nnd nN           (6) 
, where 2/)51(  . Substituting (6) into (5) and with some algebraic calculations 
we have  
2)1(,1)0(
5/))1((2)( 11

 
NN
nN nn 
 
 
N(n) in this formula generates delayed (i.e. without the first term in the classical 
sequence) Fibonacci numbers. There is no general formula for l > 2. The sequences 
corresponding to l > 2 are Fibonacci-like sequences in which each term is the sum of 
its previous l terms, and the first l terms of the sequence are increasing non-negative 
powers of 2. The growth rate of such sequences is initially higher than that of the 
simple power sequence derived in (4), which will eventually overtake the Fibonacci-
like sequences. Therefore, asymmetry pays at small carrying capacities. When 
asymmetry is rare, it remains rare if the carrying capacity of the population is 
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sufficiently large. It should be emphasised that I have only considered σ = 1 as 
asymmetry. These results might be different with intermediate levels of asymmetry. 
This is important because although there is currently no known mechanism that 
generates a well-regulated submaximal level of asymmetry, the fidelity of damaged 
macromolecules in following complete segregation asymmetry may not be complete. 
This imperfectness becomes particularly important when the number of independently 
behaving damaged molecules is small (e.g. aggregation of damaged proteins) and the 
infidelity of segregation is considerable. The effects of this type of stochasticity are 
shown in Figure 5.4. In such conditions, a mechanism which is meant to produce 
complete asymmetry will actually lead to intermediate levels of asymmetry.  
 
Figure 5.4: The effects of particle number and segregation fidelity on damage 
variation. Variance of the proportion of premitotic maternal damage received by d1, 
the daughter cell into which damaged particles segregate with a higher probability, is 
higher for smaller values of n (the number of independently behaving damaged 
particles in the mother cell immediately before mitosis) and σ, the segregation 
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coefficient. Points located on a given curve exhibit the same level of variance in 
damage, represented by the number on the curve. 
 
Figure 5.5 compares symmetric cases with asymmetric ones for the relationship 
between em and fundamental properties of the system (i.e. cell cycle duration and 
accumulated damage per cell cycle). The costs of asymmetry are inevitably taken 
from resources that could otherwise be allocated to reproductive and/or maintenance 
functions.  
 
 
 
Figure 5.5: Comparison between symmetry and asymmetry for the relation 
between maintenance investments and fundamental properties of the system (i.e. 
cell cycle duration and the accumulated damage per cell cycle). With asymmetry, 
there are lower amounts of resources available for maintenance/reproduction 
investment. With asymmetry, the cell cycle duration curve is shifted to the left (left 
panel) and the damage accumulation curve is transformed and shifted to the left (right 
panel).    
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5.4      Discussion  
5.4.1   General implications of the results 
In the first section of the model, I showed that before degradation evolves, symmetry 
is an optimal strategy unless damage accumulation during a cell cycle is significantly 
high. This case is possible with small investments in reproduction, which prolong the 
cell cycle, and in stressful environments. If resources in such environments are low, 
cells will not be able to increase the energy allocated to reproduction and the damage 
caused by stress will accumulate during the (relatively) long cell cycle to dangerous 
levels. Asymmetry is the only solution in these conditions. In the second section of 
the model, cells had already evolved degradation mechanisms. As expected, 
asymmetry evolves less readily in this case. In particular, symmetry is an optimal 
strategy when the ratio of maintenance to growth investment is sufficiently high (i.e. 
g/s > 1/D
*
). When this is not true, the condition derived in (5) opposes the evolution 
of asymmetry. It should be noted that there might be other cases in which symmetry is 
the optimal strategy. I only derived the conditions leading to two major categories of 
such cases.  
 
The third section of the model was the most general situation and considered the 
possibility of asymmetry being associated with certain costs. Potential costs of 
asymmetry have not yet been identified. Many components of the known asymmetry-
generating mechanisms have other functions in the cell. For example, heat shock 
proteins, a large family of highly conserved and constitutively synthesised molecular 
chaperones, assist refolding and degradation of misfolded proteins, and may mediate 
the upstream part of the pathway leading to asymmetric segregation of damage 
(Bardwell & Craig 1984; Kültz 2003; Liang & MacRae 1997). Two well-known heat 
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shock proteins that bind to irreversibly damaged proteins are Hsp70 (DnaK) and 
Hsp104 (ClpB) (Barnett et al. 2005; Erjavec et al. 2007; Hartl 1996; Mogk et al. 1999; 
Zimmerman et al. 2004). At least some elements required for asymmetry have 
therefore already evolved and hence natural selection could simply exploit them for a 
novel purpose without needing to pay additional costs. However, new molecular 
interactions might have been needed to be established and the costs associated with 
these inventions remain to be seen. Distal parts of the pathways that move damaged 
molecules (using the cytoskeleton) seem to be more specifically linked to the 
asymmetry mechanism. Examples of such components are certain J domain proteins 
(e.g. rsp1p in S. pombe and glsA in the simple multicellular organism Volvox carteri) 
that form a bridge between heat shock proteins and the cytoskeleton (Miller & Kirk 
1999; Zimmerman et al. 2004). The costs associated with evolution of these 
molecules may have well been significant. It has been estimated that the average yeast 
protein can change its expression only by 0.5% without a change in energy costs 
visible to natural selection (Wagner 2005; Wagner 2007). The constraint introduced 
by the limited available energy budget on changes in gene expression become 
particularly significant at large effective population sizes, where rapid proliferation is 
tightly coupled to an efficient energy metabolism (Fay et al. 2004; Townsend et al. 
2003). Recent studies on budding yeast Saccharomyces cerevisiae (S. cerevisiae) 
suggest that even single amino acid replacements (which might generate asymmetry 
here) can be subject to natural selection on the basis of their material costs (Bragg and 
Wagner 2009). I showed that the carrying capacity of the population is a critical 
determinant of early stages of evolution of asymmetry, i.e. when asymmetry was rare. 
With abundant resources in the environment, for example, we do not expect high 
selection pressures for evolution and spread of asymmetry when it is rare.     
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The condition derived for evolution of asymmetry when it is costly is not uncommon. 
It is reminiscent of a well-known evolutionary question on origin of life. In 
competition between a Malthusian replicator (capable of template-mediated self-
replication) and a one-member hypercycle (capable of both template-mediated and 
enzyme-mediated self-replication), large carrying capacities oppose the evolution of 
Malthusian replicators when they are initially rare (Michod 1999).  
 
5.4.2    Links to ageing 
The intrinsic biology of cellular ageing is closely linked to asymmetric damage 
partitioning (Ackermann et al. 2003; Johnson & Mangel 2006; Kirkwood 2005). 
Damage segregation in unicellular organisms is a strategy with several potential 
advantages including rapid growth (Evans & Steinsaltz 2007; Watve et al. 2006), 
improved damage handling (Ackermann et al. 2007; Fredriksson & Nyström 2006; 
Johnson & Mangel 2006), and more resistance against clonal senescence (Erjavec et 
al. 2008). Interestingly, neither symmetry nor asymmetry is universal. S. cerevisiae, 
Candida albicans, and S. pombe use, on average, segregation strategies σ = 0.75, σ = 
0.65, and σ = 0.55, respectively (Aguilaniu et al. 2003; Fu et al. 2008; Minois et al. 
2006). In Chapter 4, I developed a stochastic model to account for this range. Three 
parameters, namely d (damage accumulation rate), μi (damage-induced death), and m 
(proliferation rate), were found to be correlated to asymmetry. The simplest model 
which was capable of explaining more than 90% variation of the outcome of 
evolution was composed of d, m, and the interaction term d × μi. Specifically, large 
values of d and d × μi and small values of m were significant predictors of asymmetry. 
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The model was stochastic and did not include costs of asymmetry. The following 
points summarise the results of the stochastic model: 
 
1. The outcome of evolution depends both on organismal and ecological conditions. 
A significant proportion of individuals in mutation-prone populations do not 
follow the fitness-maximising level of asymmetry (as related to individual fitness) 
after the population has reached steady state distributions of segregation 
strategies.  
2. High rates of damage accumulation and severe damage with sufficiently 
detrimental effects on survival promote the evolution of asymmetry. Mutations 
that promote asymmetry are particularly favoured in harsh environments.  
3. Rapid proliferation reduces the force of selection for asymmetry. 
4. Asymmetry might be an alternative strategy to heavy investments in maintenance 
functions. 
 
Here I provided analytic proofs and considered asymmetry costs. The total energy 
budget available to the organism (the cell in unicellular organisms) is limited. 
Accordingly, the disposable soma theory of ageing is built on the trade-offs resulting 
from resource limitation and concerns the evolutionarily optimised balance between 
cellular investment in reproduction and maintenance/repair (Kirkwood & Holliday 
1979). With high rates of extrinsic mortality in nature, it is not beneficial to put more 
resources into maintenance functions than are needed for the organism to survive to 
the time of reproduction. Due to this submaximal maintenance investment, the 
organism accumulates damage, declines in its physiological functions, and thus ages. 
While investment in growth, reproduction, maintenance, and repair directly affect the 
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investor, investment in asymmetry does not. It only makes sense when one considers 
the investor's related kin. The offspring and next generations, rather than the same 
cell, benefit from asymmetry investment. Nevertheless, the costs (if any) of 
asymmetry have to be paid by the same cell and from its total energy budget. Perhaps 
the disposable soma theory needs to be expanded to include asymmetry costs.  
 
5.4.3    Transition to multicellularity 
The results of the model developed here cannot be immediately extended to 
multicellular organisms. One important reason concerns the definition of fitness. In 
unicellular forms of life, the cell is the whole organism and so the fitness of the cell is 
the same as the fitness of the organism. The well-being of the cell is equal to the well-
being of the organism and strategies that improve cell survival and/or reproduction are 
selected for in these simple organisms. This is not the case in multicellular organisms. 
All cellular strategies have to be tuned during the course of evolution and aligned with 
the benefit of the organism. Cell-level selfishness in a multicellular organism leads to 
disruption of cooperative behaviour and pathology (e.g. cancer (Michor et al. 2003)). 
Cells might even be sacrificed in order for the individual to survive and reproduce, as 
is thought to occur when intestinal stem cells preferentially undergo apoptosis 
following low-dose irradiation (Potten 2004). In spite of these issues, asymmetry has 
found its way into all kingdoms of life. Stem cell division is one example. Damaged 
proteins targeted for proteasomal degradation are asymmetrically distributed during 
mitosis in human embryonic stem cells (Fuentealba et al. 2008). Stem cell division in 
adulthood is the same. Irreversibly damaged proteins in Drosophila melanogaster 
neuroblasts and intestinal crypts of patients with protein folding disease are 
asymmetrically distributed to one of the daughter cells (Rujano et al. 2006).  
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Damage may act as a cell fate determinant by at least two ways. Firstly, it reduces the 
chances for survival. Secondly, it might attract signalling molecules. The generated 
signal may then activate certain metabolic pathways and eventually lead to altered 
cellular decisions such as growth and differentiation. Has damage and its asymmetric 
segregation been utilised by evolution at early stages of multicellularity to promote 
cellular differentiation and division of labour? Is the efficiency and activity of the 
maintenance/repair system regulated during embryogenesis in a way that damage 
levels change at specific times and at specific locations within the growing embryo? 
How much of the difference between somatic and germ-line protection against 
damage (e.g. oxidative) can be explained so? These are some of the questions that 
should be addressed in future research.  
 
5.5      Conclusions 
I developed a simple model for evolution of asymmetric non-genetic damage 
segregation in unicellular organisms and investigated the conditions in which 
asymmetry might be a beneficial strategy to evolve. The main components of the 
model were protein synthesis, damage accumulation, and damage degradation. The 
energy requirements of growth, maintenance, and possibly asymmetry were 
incorporated into the model. I suggest that asymmetry is a fundamental fitness 
modulator and if sufficiently costly, needs to be considered as part of the trade-offs 
that arise as a result of resource limitation. The most obvious application of my results 
concerns the evolutionary origin of ageing and yeast is the best known but only one 
target for testing the predictions of the present model. The model may be extended to 
include any form of non-genetic damage. Preferential segregation and accumulation 
135 
 
of extrachromosomal rDNA circles (ERC) in the mother cell have been proposed to 
contribute to yeast mother cell-specific ageing (Sinclair & Guarente 1997). One can 
choose to think of ERCs as damaged molecules and then use the idea of mother cell 
bias in asymmetric segregation (Shcheprova et al. 2008) to apply the model. Changes 
that occur to the asymmetry-related mechanisms at the transition to multicellularity 
are another interesting direction for future research.   
5.6      Appendix 
Here I show that with conditions introduced in equation (3) in the text, all cells 
survive under symmetry, that is to say, symmetry is the best strategy. By looking at 
Figure 5.1B, we realize that the condition for survival of the cell is 
 
*DDT   
Considering the equation for DT derived in section 3.2, we have 
 
 /* )]/()][(/)([)(/)0( gssggsgDggsD  
If the right-hand side of the above equation is larger than D
*
, it can easily be seen that 
everybody will survive. For this to happen we need 
 
0)]/()][/([})]/([1]{)(/[ //*   gg ssgssDggs  
, which then gives 
 
1//* }1)]/({[)]/()][/([)(/   gg ssssgDggs  (7) 
The right-hand side of the above equation is larger than 1 for g < ∆. For (7) to hold, 
we now only require  
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1)(/ *  Dggs  
Equivalently, we need 
  
0)1/( *2  Dsgg  
This requires (for the above equation to have real roots)  
 
4/)1( *Ds     (8) 
and 
 
2/))1/(4(2/))1/(4( *2*2 DsgDs    (9) 
Putting (8) and (9) together with g < ∆, we have the conditions derived in (3). Note 
that these are sufficient, but not necessary, conditions.  
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Chapter 6: Conclusions and future work 
In this thesis, I tried to show a systems-level approach to the evolution of ageing and 
age-related conditions. The approach was theoretical and spanned the range from 
unicellular to multicellular organisms, simple to complex systems, and cell-level to 
population-level. I used a variety of techniques including stochastic modelling, 
dynamical systems, and comparative physiology.  
 
In chapter 2, I attempted to address a serious ignorance in the study of beta-cell 
dynamics. The massive literature that exists on beta-cell proliferation and death (both 
during normal conditions and the course of diabetes) and intrinsic and extrinsic 
factors that regulate life/death properties of beta-cells contains little information on 
how beta-cell dynamics may be regulated within an islet. Therefore, I developed a 
rigorous mathematical model of intra-islet beta-cell dynamics. The model takes 
advantage of the latest relevant data, and is sufficiently generic to include the new 
data that become available. I demonstrated that as a physically closed system with 
birth and death processes, the islet can be studied using evolutionary concepts. 
Implications of the model, once missing parameter values are known through 
empirical work, would readily extend to long-term disturbances in glucose 
homeostasis, e.g. type 2 diabetes. Predictions of the model cover cases of stable and 
unstable diabetes. It is a major challenge to keep diabetic patients metabolically stable 
and avoid unprecedented deterioration of glucose homeostasis. Such deteriorations, 
mathematically known as bifurcations and hysteresis, can be studied in the flexible 
framework provided by the model.   
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The main theme of chapter 3, which was on beta-cell antioxidant defences, was 
hypothesis generation based on comparative data. Given the frequently observed 
conservation of metabolic and homeostatic pathways, a parsimonious explanation for 
nontrivial observations that does not require assumptions about too many new 
evolutionary inventions is always preferred. In chapter 3, I linked together, under a 
single evolutionary explanation, a number of unexplained observations on the glucose 
homeostatic system, examples being the weakness of beta-cell antioxidant defences 
compared to other tissues which is further exaggerated in females. A unifying theory 
was developed with the idea that beta-cell antioxidants are tuned to an optimal level 
so as to maximise the fitness of the organism. The optimisation is the best solution 
given costs and benefits of a potential adaptation. In order to develop the theory, 
molecular information about the production of ROS in beta-cells, ROS handling, and 
the effects of ROS on beta-cell physiology were explored and then combined with 
organism-level glucose homeostasis. This process involved considering the few 
insulin-independent tissues in the body, namely the brain and placenta (in female 
placental mammals). Given the importance of the brain and placenta in the evolution 
of vertebrates, and mammals in particular, the theory had to deal with co-evolution of 
glucose homeostasis, brain, placenta, beta-cells, and the stress response. And hence 
we can see organism-, and even higher-, level insights resulting from the theory. The 
major outcome of theory is a proposed history for the evolution of beta-cells since 
their emergence until their current status. The theory may be tested once data, 
containing information about beta-cell antioxidant status, become available, especially 
from extant species representative of the time when vertebrates and/or mammals first 
evolved. One way to test the predictions of the model in the lab would be through 
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manipulation of beta-cell antioxidant gene expression and looking at the fitness of the 
organism in the long term.        
 
Chapter 4 was about the evolutionary origins of asymmetric damage segregation in 
unicellular organisms. The origins of ageing may well share the same route which 
gives the modelling work in chapter 4 particular importance. A number of recent 
studies have been done on evolution of damage segregation, and the results are 
definitely illuminating. However, the simplicity of most available models does not 
allow for successful explanation of all available data. The current literature contains 
valuable information about the asymmetry of damage segregation in Candida 
albicans, budding yeast, and fission yeast. The three organisms seem to follow three 
different strategies for damage segregation and a model to link these differences to 
adaptive evolution is lacking. Also, the intrinsic stochasticity that results from the 
small number of entities at the cellular level has not been incorporated in previous 
models. Using a simulation approach, I developed models of damage segregation in a 
generic unicellular organism and found the optimal segregation strategy that is 
expected to evolve under given conditions. Potential determinants of the optimal 
segregation strategy were both related to cellular processes (proliferation, death due to 
damage accumulation) and environmental factors (damage accumulation). The 
optimal strategy is the one that maximises Darwinian fitness under the given 
conditions. This approach has not been used in previous work. Future directions for 
research in this field include obtaining information on segregation strategies used by 
other unicellular organisms, the ecological conditions under which they have evolved, 
and the intrinsic cellular processes that determine their reproduction and sensitivity to 
damage. Once this information is available, one can easily test the prediction of the 
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model regarding the optimal strategy that is expected to evolve under the conditions 
of one‟s interest.   
 
Chapter 5 presents an explicit analytical solution to the problem of asymmetric 
damage segregation. Costs of asymmetry were ignored in chapter 4 because the 
parameter space to be spanned would otherwise be too large. The advantage of this 
simplistic assumption, of course, was the simplicity of the model and the convenience 
with which the results in a stochastic context could be conceived. A more rigorous 
treatment including fundamental physiological trade-offs and potential costs of 
asymmetry was provided in chapter 5. The most important missing information to be 
available before quantitative predictions can be made from the model is data on costs 
of asymmetry. The signalling pathways involved in damage segregation use energy, 
and energy has to come from the cell‟s total energy budget. However, the significance 
of the costs relative to the total available budget is not known. Specifically, if the 
costs are not significant and do not seriously affect the cell‟s energy-determined trade-
offs, a simpler version of the model developed in 5.3.1 and 5.3.2 may be applied. I 
speculated on what might have happened at the transition to multicellularity and how 
unicellular damage segregation strategies might have been used/co-opted at the 
transition into the developmental timeframe of the multicellular body. A better 
understanding would be feasible through comparative genomics studies that look at 
the conservation of genes and pathways across major evolutionary transitions. Higher 
degrees of conservation, in structure or function, would increase the likelihood of the 
segregation strategies being co-opted from the unicellular to the multicellular world.          
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In conclusion, the models and concepts developed in this thesis can be considered as 
case studies on application of an evolutionary systems-level approach to different 
aspects of ageing. The toolkits developed and used in these projects are by no means 
the only available tools and the ageing features that were studied are only a few of the 
many areas in which ageing research may be carried out. Limitations of this thesis are 
mostly related to the lack of experimental data to make more plausible biological 
assumptions, back up the results, and test the predictions. This highlights the 
importance of an interdisciplinary ageing research group. Nevertheless, as new data 
emerge in laboratories, the predictions of the models may be tested. Depending on the 
fit, the models can be refined if necessary.    
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